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ABSTRACT
Lung cancer is the leading cause of cancer-related death in the United States and
worldwide. Early detection of lung cancer can help improve patient outcomes, and survival
prediction can inform plans of treatment. By extracting quantitative features from computed
tomography scans of lung cancer, predictive models can be built that can achieve both early
detection and survival prediction. To build these predictive models, first a detected lung nodule
is segmented, then image features are extracted, and finally a model can be built utilizing image
features to make predictions. These predictions can help radiologists improve cancer care.
Building predictive models based on medical images is the basis of the budding field of
radiomics. The hypothesis is that images contain phenotypic information that can be extracted to
aid prediction and that automated methods can detect some things beyond human detection.
With improved detection and predictive models radiomics aims to help assist radiologists and
oncologists provide personalized care.
In this work a model is presented to predict long term survival versus short term survival.
Forty adenocarcinoma diagnostic lung computed tomography (CT) scans from Moffitt Cancer
Center were analyzed for survival prediction. These forty cases were in the top and bottom
quartile for survival. A decision tree classifier was able to predict the survival group with an
accuracy of 77.5% using five image features chosen from 219 using relief-f.
Another contribution of this work is a model for predicting cancer from suspicious
nodules. The national lung screening trial was used to build a training set of 261 screening CTs
and a test set of 237 CTs. These images were taken at the initial screening, one and two years
vii

before cancer developed. From these precursor images, which nodules developed into cancer,
could be predicted at 76.79% accuracy with an area under the receiver operating characteristic
curve of 0.82. A risk score was also developed to provide a measure of risk during screening.
The developed risk score performed favorably in predictive accuracy compared to Lung-RADS
on this data set.
The Data Science Bowl was also entered and this work examines the knowledge gained
from a large-scale competition to improve imaging. In this competition participants were tasked
with predicting cancer from 1397 training cases on 506 test cases. The winning entry performed
with a logLoss of 0.39975 while making use of all the training data while our entry scored
1.56555 with a different set of training data. A lower logLoss shows greater accuracy. This work
explains our approach and examines the winning entry.
An overview of the state of radiomicis as it applies to lung cancer is also provided. These
contributions of predictive models will help to provide decision support to medical practitioners.
By providing tools to the medical field the goal is to advance automated medical imaging to aid
clinicians in creating diagnosis and treatment plans.
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CHAPTER 1: INTRODUCTION
1.1

What is Radiomics?
In “Radiomics: Images Are More than Pictures, They Are Data” by Gillies et al. ,1

radiomics is defined as the “high-throughput extraction of quantitative features that result in the
conversion of images into mineable data and the subsequent analysis of these data for decision
support.” Radiomics differs from computer-aided diagnosis and detection (CAD) systems. While
both use medical images from computed tomography (CT), magnetic resonance (MR), and
positron emission tomography (PET), CAD systems are designed to detect or diagnose a disease.
Radiomics, on the other hand, extracts and stores features for hypothesis testing and to develop
decision support tools. Radiomics is intended to supply imaging biomarkers for disease
detection, diagnosis, prognosis, treatment prediction, and monitoring. Radiomics has grown
around oncology due to the support of the National Cancer Institute and the Quantitative Imaging
Network, but can be used for any disease. The workflow consists of imaging the patient,
identifying regions of interest (segmentation), feature extraction, and data mining and model
building. Images acquired are standard of care images. Regions of interest can be the whole
tumor or just parts, known as habitats. Features extracted can be semantic or agnostic. Semantic
features are what radiologists commonly use to describe lesions such as shape, location,
vascularity, spiculation, necrosis, and attachment. These features can be quantified with the aid
of a computer as well. Agnostic features are mathematical descriptions, such as histograms of
intensity, Laws features, and wavelets. The features are stored in databases. These databases
must have enough patients so that the studies and models built have enough power to be
1

generalizable, but the data should also be of high quality and well curated. Once the data is
gathered, data mining/machine learning, and statistical approaches can be applied. Challenges for
radiomics include problems of reproducibility, data size and sharing, and deciding on standards
for analysis. These problems can be overcome and in the reading room of the future a radiologist
will have access to information gleaned from radiomics while new information is automatically
shared.
Besides image features, plasma based microRNA signatures are another source of
biomarkers for lung cancer. Sozzi et al. built a microRNA signature classifier (MSC) and tested
it retrospectively on data from the Multicenter Italian Lung Detection (MILD) trial.2 The authors
were able to obtain an 87% sensitivity and an 81% specificity in detecting lung cancer. This was
better than the low-dose computed tomography (LDCT) results of 79% sensitivity and 81%
specificity. However, the predictions were done at the time of diagnosis and it is unknown how
they would perform across a wider time gap.
The four advances that led to the rise of radiomics, according to Lambin et al., are
innovations in medical devices, innovations in imaging agents, standardized protocols allowing
quantitative imaging, and innovations in imaging analysis.3 The authors define radiomics as “the
high-throughput extraction of image features from radiographic images” with the goal of
inferring proteo-genomic and phenotypic information.
Better medical devices allow for viewing finer details of tissue composition. Improved
imaging agents can reveal pathological processes such as hypoxia marking in PET imaging.
Standardization, which still needs improvement, allows for reproducible results. With better
analysis of results, better computer-assisted detection systems can be produced. These
innovations will allow for advances in radiomics.

2

1.2

Why Radiomics Matters – A Lung Cancer Perspective
As of 2017, lung cancer is the second most commonly diagnosed cancer and the leading

cause of cancer related deaths in both men and women.4 Screening is known to reduce mortality
in lung cancer for long-term smokers. In fact, screening with low dose spiral computed
tomography has been shown to reduce mortality by 20% compared to using chest x-rays in adults
with a history of smoking. Screening finds nodules in the lungs, which may become cancer.
Screening is important and can be improved through radiomics. Zhu et al. showed that a support
vector machine compared favorably to radiologists when classifying solid pulmonary nodules.5
Radiomics provides a way for images to be analyzed in a standardized manner and can provide
prognostic information.6 Radiomics is a non-invasive tool for diagnosis and can be easily
incorporated into current medical imaging practices. CT images also provide a picture of the
whole lung nodule, whereas a biopsy is at a specific part of a nodule and cancer is not believed to
be homogeneous.
1.3

Contributions
This dissertation is based upon the previous work done in radiomics. The design of image

feature extraction and model building for prediction is informed from the work by the likes of
Way et al. who distinguished benign and malignant nodules from texture features.7 Zhu et al.
showed the value of support vector machines in classifying malignant pulmonary nodules, which
is an approach used in this dissertation.5 Aerts et al.’s workflow of CT imaging, feature
extraction, and analysis is similar to the workflow used in this work.6 This dissertation seeks to
build upon previous research that has already been shown to work.
This dissertation outlines a model for predicting survival. Adenocarcinoma cases were
predicted at the time of diagnosis into short-term or long-term survival classes. A decision tree
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classifier using the top five of 219 features selected per fold in a leave-one-out cross validation
was able to obtain an accuracy of 77.5%.8 This was the first study to predict survival at time of
diagnosis using image features on a heterogeneous data set. The data from this study is available
at The Cancer Imaging Archive.9
This dissertation provides a model for predicting the malignancy of lung nodules. Using
two cohorts10 of baseline screening CTs from the National Lung Screening Trial (NLST),11 we
were able to predict whether a nodule would become cancerous within 1 year at 80% accuracy
and if a nodule would become cancerous within 2 years at 79% accuracy.12 The Radiomics
model outperformed the Lung Imaging Reporting and Data System (Lung-RADS)13 as well as
outperforming a prediction from volume alone. A novel risk score was generated from this
model, which was better than any we could find.
While there are still many challenges to be met in every step of a radiomics workflow as
outlined by Kumar et al.,14 such as different scanner types and trouble sharing data, these
challenges will be overcome and present many opportunities for innovation. The research
reported here provides a new baseline.
1.4

Dissertation Organization
Chapter 2 provides background information on lung cancer, radiomics, segmentation,

feature selection, classification, and metrics for analysis. Chapter 3 applies radiomics to predict
survival of non-small cell lung cancer using CT image features. Chapter 4 predicts malignancy
of lung nodules from screening CT scans. Chapter 5 discusses the Data Science Bowl 2017.
Chapter 6 provides concluding remarks.
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CHAPTER 2: BACKGROUND
2.1

Lung Cancer
The leading cause of cancer-related death in the United States and worldwide is lung

cancer.15,16 Any improvement in outcome will help a large number of people. In 2016, lung and
bronchus cancer were estimated have the most deaths for both men and women, but also had the
second most new cases for both sexes too.17 There were an estimated 224,390 new cases of lung
cancer in 2016 accounting for 14% of cancer diagnoses. Smoking is the primary risk factor
accounting for 80% of lung cancer deaths in the US. Symptoms of persistent cough, blood in
sputum, chest pain, shortness of breath, and recurrent pneumonia and bronchitis are not usually
present until the cancer has advanced.
For this reason early detection for at risk patients is important. Screening with low-dose
spiral computed tomography (LDCT) can reduce mortality by 20%.11 The type of lung cancer
determines treatment options.
Early stage non-small cell cancer is treated with surgery. Later stage non-small cell
cancer is treated with chemotherapy, targeted drugs, or immunotherapy. Small cell lung cancer is
treated with chemotherapy or radiation. Overall one-year survival is 44% while five-year
survival is 17%. Small cell lung cancer, which accounts for 13% of cases, has a five-year
survival of 7%. Non-small cell lung cancer, which accounts for 83% of cases, has a five-year
survival of 21%.
Oberije et al. did a prospective study comparing the predictions of doctors to models for
treatment outcomes of non-small cell lung cancer patients.18 Radiation oncologists predicted 25

year survival after the first consultation for 121 patients and predicted 2-year survival after a
radiation treatment plan was made for 35 patients. For doctors the AUC was 0.56 after
consultation and 0.56 after the treatment plan. The model had an AUC of 0.71 and 0.78. These
results were statistically significant at the 0.05 level, and the authors concluded that clinicians
would benefit from decision support systems.
2.1.1

Lung Image Reporting and Data System (Lung-RADS)
The current method for lung nodule classification is the lung image reporting and data

system (Lung-RADS) which was developed by the American College of Radiology (ACR).13
The categories that cases are assigned into are Incomplete (0), Negative (1), Benign Appearance
(2), Probably Benign (3), Suspicious (4a, 4b, 4x), Other (S), and Prior Lung Cancer I.
Nodules are considered benign if they are less than 6mm or new and less than 4mm for
solid nodules. If they are part solid nodules, less than 6mm is considered benign. For non-solid,
ground glass, nodules, less than 20mm or greater than 20mm and not growing is considered
benign. Suspicious nodules are defined as greater than or equal to 8mm or new and greater than
6mm for solid nodules. For part solid nodules greater than or equal to 6mm are considered
suspicious.
The recommended management is annual screening for benign appearance nodules, 6
month LDCT for probably benign nodules, 3 month LDCT for 4a suspicious nodules, and chest
CT or PET for 4b and 4x suspicious nodules. The probability of malignancy for benign
appearance nodules is less than 1%; this accounts for 90% of the population.
For probably benign nodules the probability of malignancy is 1-2%, and the population
percentage is 5%. Suspicious 4a nodules have a 5-15% chance of malignancy and account for
2% of the population. Suspicious 4b and 4x nodules have a greater than 15% chance of
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malignancy and account for 2% of population. These categories helped to standardize lungscreening interpretations.
Pinsky et al. scored Lung-RADS on the National Lung Screening Trial as part of a
retrospective study.19 Lung-RADS performed favorably compared to the screening criteria in the
NLST protocol, which considered a positive screen to be if a nodule was greater than 4mm. At
baseline Lung-RADS had a false positive rate of 12.8% whereas the NLST protocol had a false
positive rate of 26.6%. However, sensitivity was also reduced. At baseline the sensitivity using
Lung-RADS was 84.9% compared to 93.5% in NLST.
The authors concluded that the reduction in the false positive rate was weighted towards
lower risk individuals and that 5-year survival did not differ. This could lead to reduced harm
and cost by using the Lung-RADS criteria, but a study would be needed that was not
retrospective.
2.1.2

McWilliams Model
McWilliams et al.20 proposed another model for predicting malignancy in baseline lung

nodule CT scans. This model, also known as the Brock University cancer prediction equation,
uses age, sex, family history, emphysema, nodule size, location, solidity, count, and spiculation
to make a prediction.
The model divided prediction into low risk (5% chance of developing cancer), medium
risk (5% to 10% risk), and high risk (more that 10% risk). McWilliams et al. tested their model
on the Pan-Canadian Early Detection of Lung Cancer Study and found their model to have an
area under the receiver operating characteristic curve (AUC) of 0.9. This study showed that for
20% of the participants the largest nodule was not the malignant one on follow-up. By utilizing
more clinical factors they were able to produce an accurate model.

7

2.2
2.2.1

Lung Cancer Radiomics
Historical
In 2003 Kido et al. analyzed internal and peripheral textures of adenocarcinoma and

squamous cells using fractal analysis.21 The data set consisted of thin-section computed
tomographies from 70 patients. The authors were able to differentiate bronchioloalveolar cell
carcinomas (BACs), which have a good prognosis, from other bronchogenic carcinomas
(nonBACs). It should be noted that bronchioloalveolar carcinoma is a classification no longer in
use. The term has been replaced with adenocarcinoma in situ and minimally invasive
adenocarcinoma for small adenocarcinomas and invasive mucinous adenocarcinoma for large
adenocarcinomas.22 The fractal dimensions from BACs were greater than those from nonBACs.
The authors concluded that the greater fractal dimensions (FDs) for the BACs corresponded to
more complex structures, which could be used for prognosis.
In 2006 Way et al. attempted to distinguish between benign and malignant nodules using
3D active contours.7 Using a data set of 96 nodules the model was based on 2D active contours
with the addition of 3 different 3D components: 3D gradient, 3D curvature, and mask energy.
Using leave-one-out resampling the CAD system achieved an AUC of 0.83.
In 2007 Segal et al. correlated image features with global gene expressions in
hepatocellular carcinoma.23 Using CT scans of liver cancer 138 image traits were identified and
filtered using a Pearson’s correlation cut-off of 0.9 to reduce to 32 traits. There were 28 of those
32 image traits that were informative of gene expression. The training set included 28 human
hepatocellular carcinomas (HCCs) with 6,732 genes and the test set had 19 HCCs. The 28 image
traits predicted variation in expression of 5,282 of the 6,732 genes (78%). The authors concluded
that genomic activity in the liver could be monitored with noninvasive imaging.
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In 2008 Al-Kadi and Watson were able to differentiate between aggressive and nonaggressive malignant tumors (high and low metabolic).24 Fifteen patients were injected with
fluorodeoxyglucose, a contrast agent, and at least 11 time-sequenced CT images were analyzed
for fractal texture. This method yielded 83.3% accuracy in identifying tumor aggressiveness.
In 2009 Samala et al. looked for the optimum image features in thin section thoracic
computed tomographies for use in computer-aided design (CAD) systems.25 The authors
compared the correlation between 11 calculated image features to 9 radiologist-annotated
features from 42 regions of interest of 38 patients. Of the 11 calculated image features 3 were
found to be redundant for both nodules and non-nodules. A combination of features performed
better in classification with a neural network than radiologist annotation alone. Using the
optimum combination of features, which included sphericity, area, maximum contrast, and
maximum eccentricity, the authors obtained the maximum F-test of 0.821 and 0.643 for
malignant and benign nodules compared to other feature sets. They concluded that calculated
features should be considered for CAD systems and must be evaluated on the total impact that
those features have.
In 2010 Ganeshan et al. found that textures in CT images of non-small cell lung cancer
correlated with glucose metabolism and cancer stage.26 Images were first filtered using a
Laplacian of Gaussian spatial band filter into fine (2 pixels, 1.68mm), medium (6 pixels,
5.04mm), coarse (12 pixels, 10.08mm), and unfiltered. Then the mean grey level, entropy and
uniformity texture features were extracted. With 17 patients the authors found that coarse texture
features correlated with standardized uptake value of fluorodeoxyglucose and fine texture
features correlated with stage. This study gave an early indication that texture image features
could be prognostic about non-small cell lung cancer.
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In 2010 Lee et al. developed a two-step CAD system for the identification of benign and
malignant pulmonary nodules.27 It was tested using leave-one-out cross validation on 125
nodules. The authors’ ensemble method, which combined a genetic algorithm28 for feature
selection and a random subspace method,29 was able to perform better than using either approach
individually with classification using linear discriminant analysis.
In 2010 Zhu et al. showed how support vector machines30 could improve classification of
solitary pulmonary nodules (SPNs).5 Using 77 biopsy-confirmed CT cases of SPNs, 67 features
were extracted and selected down to 25 using a genetic algorithm.
The classification results of the support vector machine were compared to six senior
radiologists. The authors did not find a significant difference when comparing linear, Gaussian,
polynomial, and sigmoid kernels. They found that the support vector machine performed
favorably to radiologists obtaining an AUC of 0.8748 compared to 0.8178 for senior radiologists
with 20 years of experience and 0.7640 for junior radiologists with 2 to 5 years of experience.
Support vector machines also used many of the same features for decision making as the
radiologists.
2.2.2

Contemporary
In the 2012 paper “3D Slicer as an image computing platform for the Quantitative

Imaging Network” three institutions explained how they used the 3D slicer imaging software.31
3D Slicer is an open-source application for clinical practice; similar to a clinical workstation it
provides visualization, segmentation and registration, but 3D Slicer is also a programming
platform allowing for data communication, visualization, and user interface development.
Brigham and Women’s Hospital uses 3D slicer for the visualization of parameters from the
prostate mpMRI data set. The University of Iowa used 3D Slicer for measuring PET-imaging-
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based quantitative indices in a tumor region. Massachusetts General Hospital used 3D slicer to
analyze therapeutic response in glioblastoma multiforme. 3D Slicer has been applied to many
organs and imaging modalities.
“Effect of Texture Features in Computer Aided Diagnosis of Pulmonary Nodules in LowDose Computed Tomography” in 2013 by Henry Krewer et al. used the LIDC data set to predict
malignant and benign pulmonary nodules.32 The authors obtained an accuracy of 87.88%
combining shape and texture features, an improvement over shape features alone.
Aerts et al., in 2014, promoted the thinking that tumor phenotypes could be visualized
non-invasively using medical imaging.6 They studied 1,019 lung and head-and-neck cancer
patients extracting 440 image features composed of intensity, shape, texture, and wavelet
categories. Using unsupervised clustering, the authors found three clusters of patients and found
a significant association with primary tumor stage, general tumor stage and histology. The
authors found a significant difference in survival for 238 features when the median feature of
their Lung1 data set was compared to the Lung2 validation set. There were 66 features from
Lung1 that were prognostic of survival on Lung2, Head and Neck1, and Head and Neck2. A
radiomics signature was proposed consisting of statistics energy (density), shape compactness
(shape), grey level nonuniformity (heterogeneity), and wavelet grey level nonuniformity
(heterogeneity). The proposed signature was validated using the concordance index and showed
better prognostic performance than volume as well as better or comparable performance than
TNM staging. The four signature features also had significant associations with different geneexpression profiles indicating they describe different biologic mechanisms.
Shen et al. used a multi-scale convolutional neural network to extract features for
classifying benign and malignant nodules in 2015.33 This method uses nodule patches instead of
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segmentations. The patches were cubes of 96, 64, and 32 pixels surrounding the nodule. These
patches were input into a multi-scale convolutional neural network.
To test accuracy, 1375 nodules with approximately a 2:1 benign to malignant ratio from
the Lung Image Database Consortium and Image Database Resource Initiative34 were used in a
five fold cross validation. The authors found a classification accuracy of 86.84% using a random
forests classifier and concluded that their proposed method provided descriptive features using
patches.
In 2016, Wu et al. explored classifiers’ ability to predict histology, which could be used
to determine treatment of lung cancer.35 The authors used a data set consisting of 152
adenocarcinoma patients and 51 squamous carcinoma patients from the MAASTRO clinic in
Maastricht, the Netherlands, for training. For testing, the authors used CT images from 62
adenocarcinoma patients and 90 squamous carcinoma patients from Radboud University Medical
Center in Nijmegen, the Netherlands. For classification, 440 3D image features were used from
CT images that were collected before the patients were treated with radiotherapy or
chemoradiation. Using univariate analysis, 53 features correlated with histology. Three
classifiers were explored, Naïve Bayes, Random Forests with 100 trees, and K-nearest neighbors
with K set to 9. The authors tried 24 different feature selection methods with Relief-f having the
top AUC for all three classifiers. The highest AUC was 0.72 obtained with a Naïve Bayes
classifier with five features found using Relief-f. The authors concluded that while the
classification showed promise, a prospective study was needed that incorporated clinical and
genomic data.
Lee et al. gave a thoughtful overview of radiomics in 2016.36 The authors defined
radiomics as “a field of study in which high-throughput data is extracted and large amounts of
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advanced quantitative imaging features are analyzed from medical images” consisting of
identifying regions of interest, extracting features, and building predictive models. Lung cancer
is a genetic disease that results in unchecked cell proliferation. Genomic heterogeneity exists
within a single tumor which gives rise to tumor habitats. Precision medicine should be able to
identify the treatment responses for all of the tumor habitats. Radiomics provides a method for
examining these habitats across time and non-invasively in a way that is impractical with
multiple biopsies.
The authors define four types of radiomic features related to specific aspects of a tumor.
Morphological features describe the physical aspects of a tumor such as shape and volume.
Statistical features are comprised of histogram and texture features. Regional features describe
subregions within a tumor. Model-based features include fractal dimensions, which describe
intrinsic shape. Radiogenomics match radiomic phenotypes to genomic information. The
challenges for radiomics as a developing field include a reliance on retrospective studies, feature
variability, differing imaging techniques, study replication, and incorporating other information
such as clinical, pathological, and genomic information.
In 2016 Fave et al. looked for the best way to calculate radiomic features.37 The authors
compared three preprocessing methods and studied how they affected a feature’s dependence on
volume and prognostic ability. There were 134 non-small cell lung cancer patients with CT
images used. The filtering methods applied were 8 bit depth resampling, Butterworth smoothing,
both of those filters, and no filter. Of the features considered, five features were entirely volume
dependent: busyness, coarseness, grey-level non-uniformity, run-length non-uniformity, and
energy. Most of the features, 39 of 55, had at least one preprocessing technique that resulted in
significant prognostic value as measured with Cox proportional hazard models. Four features had
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significant prognostic value regardless of the preprocessing technique: high grey-level run
emphasis, low grey-level run emphasis, histogram mean, and coarseness. The authors concluded
that smoothing using a Butterworth filter increased prognostic value but also increased the
volume dependence of the feature.
In 2016 Scrivener et al. gave an overview of 22 articles in radiomics.38 The authors
outlined the workflow of radiomics as image acquisition, identifying volumes of interest,
segmentation, feature extraction, and model development and validation. They note that
radiomics has a risk of overfitting a large number of features to a small amount of data. Also
only 5 of the articles reviewed were externally validated. Still the authors concluded that
radiomics has great potential both in diagnosis and prognosis of lung cancer.
2.2.3

Challenges of Radiomics
In the 2012 article “Radiomics: the process and the challenges” Kumar et al. outlined the

various challenges present when applying radiomics.14 These were divided into each of the steps
necessary for classification.
Image acquisition and reconstruction, the first step, has a choice of different models and
parameters of the scanners causing variances in slice thickness and reconstruction. Also, there is
difficulty obtaining large data sets with sufficient patients with similar types and stages of
disease to power studies. The first issue can be combated with studies to identify features that are
stable across patients and time. As well as, transforming images to a common thickness and
field of view. The second issue can be dealt with through cooperation between institutions and
by sharing data.
The second step is segmentation, dividing the images into tumor and normal tissue. The
challenge is that there is no definitive answer to the question of what is the correct segmentation
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and even experienced radiologists’ segmentations differ from one another. A possible solution is
that automated methods can provide, at least, a consistent segmentation.
The third step is feature extraction. Features can be divided into various categories
including tumor intensity histograms, shape based features, and texture based features. A large
number of features can be derived. In order to reduce the number of features to those that are
reproducible, informative, and non-redundant, it is suggested to use test-retest to look for stable
features, a cut-off for dynamic range, and correlation.
The next step is data sharing. Data must be de-identified in order for it to be shared. Data
used by researchers is often different from that used by clinicians. Metadata may also need to be
stored. The final step is analysis where findings are sought to aid clinical practice. A problem
with analysis is that there are many tests that can be performed, but the size of the data is fairly
small. To help account for false positives a Bonferroni correction can be applied. These are the
foreseeable problems to be overcome in radiomics.
2.3

Lung Cancer Segmentation
Before features are extracted from an image, the image is segmented to delineate the

nodule from the background. The lung is also segmented which allows for features about how
attached the nodule is to the lung. In “Automated delineation of lung tumors from CT images
using a single click ensemble segmentation approach” Gu et al. present in extension of the “Click
and Grow“ algorithm.39 The “Click and Grow” algorithm is semi-automated, requiring a starting
point from a user, then expands the boundary of the segmentation until an intensity cutoff criteria
is met. To overcome the problems of inconsistent segmentations, multiple human interactions,
and unsatisfactory boundaries of the “Click and Grow” algorithm an ensemble method was
proposed. The ensemble method first uses “Click and Grow” to get an initial boundary, then
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selects random seed points within the boundary. These new seed points are used to grow children
regions. These regions are compared to the initial segmentation for intensity mean, standard
deviation, shape, and connection to the main tumor.

If those criteria are met, the new

segmentation is merged. The ensemble method required less human interaction in cleaning up
segmentations and also had better agreement between two different users.
Another way to segment an image is Otsu’s method.40 In this method shades of grey, grey
levels, are separated into foreground and background, or as applied to our segmentation problem,
nodule and lung. The grey levels are differentiated based on a threshold with all pixels below the
threshold belonging to one class and all pixels above the threshold belonging to the other class.
The threshold is chosen so that it maximally separates the two classes of pixels, this is an
optimization problem to minimize the within class variance, maximize the between class
variance, and minimize the total variance levels. When a threshold is found then the nodule is
segmented.
Gomathi and Thangaraj segmented lung images using a possiblisitic fuzzy c means
algorithm.41 They extended fuzzy c means clustering to better the handle noise found in medical
images.

Their modification was to allow the distance measurement to be influenced by

surrounding pixels. In the original fuzzy c means clustering, by Bezdek,42 pixels can have
membership to multiple clusters. The pixels are randomly assigned to cluster and then iteratively
assigned values to clusters until the change in cluster membership is below a threshold. When the
algorithm converges the clusters are set.
Gomathi and Thangaraj’s approach allows neighboring pixels, within a set window size,
to influence the membership of a pixel. The authors found their approach helped compared to the
original fuzzy c-means clustering algorithm when compared to manually segmented images.
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Hu et al. devised an automated lung segmentation method consisting of three steps.43 In
the first step a threshold is applied to the grey level to find the region that is the lung. The second
step divides the left and right lung. This step is accomplished by finding the anterior and
posterior junctions using dynamic programming. In a graph with weights that are grey levels, the
maximum cost path is the junction line. In the third step the boundaries are smoothed with
morphological operations.
The results were compared to the segmentations of two image analysts on eight subjects
imaged three times. The difference in volume between the method and the image analysts was
0.8 pixels root mean squared. The difference between subjects across the three scans had an
average difference of 2.75% with a standard deviation of 2.29%.
Pu et al. proposed a method for lung segmentation designed to better account for
juxtapleural nodules called adaptive border marching.44 The first step is to preprocess images by
Gaussian smoothing, grey-level thresholding, and floodfilling to remove non-lung regions. After
the preprocessing has finished an initial border is computed then adaptive border marching can
start.
Adaptive border marching consists of drawing lines around the border at a fixed length
called a step. In this way, one step after another, the algorithm marches around the border
reducing concavities due to the step length. In order to avoid oversegmentation, the step size is
adaptive and decreases when concavity is greater than a threshold. When judged on 20 data sets
this algorithm had an average oversegmentation of 0.43% and an average undersegmentation of
1.63%.
Sun et al. proposed an algorithm for lung segmentation using a robust active shape
approach.45 This approach consists of three steps. First, ribs are detected to aid in the placement

17

of the active shape model. Second, the active shape is placed. This shape is learned from a data
set of previously segmented lungs. Third, the segmentation is optimized using a global optimal
surface finding method that employs the maximum-flow algorithm. The segmentation algorithm
was tested on 60 cases and had a Dice coefficient of 0.975 ± 0.006 and a mean absolute surface
distance error of 0.84 ± 0.23mm.
2.4

Classifiers

2.4.1

Decision Trees
A decision tree classifier has a tree structure and J48 is a Java implementation of

Quinlan’s C4.5 release 8 decision tree classifier.46 This is an extension of Quinlan’s earlier work
on decision trees.47 The leaves of the tree represent classes to which examples are assigned and
the internal nodes, where the tree branches, are the decisions. Decisions are based on values of
an attribute such as if a value is greater than x, take the left branch, otherwise take the right
branch.
To traverse the tree start at the root and follow each decision until you arrive at a leaf.
These decisions can easily be turned into rules by making an “if” statement for every internal
node’s test “anded” together and a “then” statement for the class of the leaves. The trick is to
choose decisions for the internal nodes that make for a simple, yet accurate tree. Looking at the
information gain or entropy can make a compact tree.
!"#$%&' &( , &* , … , &, = −&( log &( −&* log &* … −&, log &,
The pi’s are the percentage of examples assigned to each of n classes in the above
equation.

Pruning of the tree can be achieved with the cost-complexity method from the

Classification and Regression Trees (CART) learning system. Subtrees are pruned with the
smallest increase in error relative to their size, cost-complexity pruning.48

18

Alternatively, reduced error pruning could be done on a separate training set, but that
would reduce the amount of available data. Instead C4.5 uses a formula to project the expected
error at a leaf/internal node from the observed error. In Weka’s implementation,49 a confidence
limit, by default 0.25, is used to estimate the error and if the parent node has equal to or less error
when removing its leaves then the tree is pruned. The minimum number of cases per leaf is
usually set to two.
To handle missing attributes there are a variety of approaches. The instance can be
ignored; however this leads to a reduction in the available data. Another option is to treat missing
attributes as their own value. A third option is to allow the example to partially go down several
branches based on the likelihood for that feature.
2.4.2

Random Forests
Random Forests50 is an ensemble classifier comprised of decision trees whose class

predictions are voted and the end result is the most popular class. The number of decision trees
can be set as a parameter in Weka with each tree choosing the best feature from log 2 the total
number of features chosen randomly, and bagging is used to select the training set. Bagging is a
method that combines multiple classifiers by voting. These classifiers are trained on multiple
versions of the data.51
2.4.3

Naïve Bayes
The Naïve Bayes classifier52 is a simple probabilistic method based on Bayes’ rule of

conditional probability,48 which says that given a hypothesis H, and an event E that the
probability (Pr) of H conditional on E is:
Pr H E =

PR E H Pr H
PR[E]

This formula is used to compute the posterior probability of each class for a case by normalizing
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the output to one. For a two-class problem with H being the conditional probability of a class and
output1 representing the value for class1 (output2 for class2), you can find class1’s probability as
follows:
PR class1 =

output1
output1 + output2

Then the class with the largest probability for that case is the prediction. There is an
assumption that the features are independent, which is rarely the case. However, this classifier
does reasonably well even when that assumption is broken. Missing values are easily handled by
omitting that feature’s probability. If one attribute is zero in the training set, to help keep it from
zeroing all the remaining attributes it is modified by a constant value, called the Laplace
estimator, which can be added to both the numerator and the denominator. Weka’s
implementation49 is based on the paper “Estimating Continuous Distributions in Bayesian
Classifiers” by John et al..53
2.4.4

RIPPER
JRIP is a Java implementation of the RIPPER algorithm,54 repeated incremental pruning

to produce error reduction. The algorithm is split into a build phase and an optimize phase.
During the build phase rules are added greedily until the accuracy is perfect (or as near as
possible) and then pruned. This process continues until all of the examples are covered, the
description length is too large, or the error rate is too high.
During the optimize stage, rules are again grown and pruned, with new rules grown from
empty antecedents but also adding onto previous rules. If either of these has a shorter description
length than the original rule then it replaces the original rule. Weka’s49 implementation of JRIP
uses the default values of three folds, a minimum weight per instance of two, and two
optimization runs.
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2.4.5

Support Vector Machines (SVMs)
Support vector machines can transform input data into a higher dimensional space. In this

higher dimensional space it is typically easier to separate distinct classes from one another with a
linear decision surface called a hyperplane. The hyperplane maximally separates the classes. The
points on the border, which determine the hyperplane, are called support vectors, named by
Cortes and Vapnik who invented the statistical learning theory upon which SVMs are based.30
Finding the support vectors can be reduced to a quadratic optimization problem.
Kramer et al. showed that support vector machines work on a variety of problems
including the Letter, Page, Pendigit, Satimage, and Waveform data sets.55 A popular
implementation is libSVM developed by Chang and Lin.56 It allows for errors, points on the
wrong side of the hyperplane, which can be dealt with using a cost parameter. Different kernels
can also be chosen to construct hyperplanes that are non-linear, such as a radial basis function or
sigmoid kernel, which has a parameter gamma.
The cost and gamma parameters can be found using a grid search, which is an exhaustive
search on training data within a specified range. There is precedent for using SVMs on CT
images. Dehmeshki et al.57 were able to apply support vector machines in the construction of
Computer aided Detection (CAD) using thoracic CT images for automated nodule detection.
WLSVM was the Weka interface used for libSVM.58
2.5

Feature Selection
When the number of features increases the performance of classifiers declines for

decision trees.59 To reduce the number of features there are two methods that can be employed,
besides embedded feature selection which is specific to a particular type of classifier. Filter
feature selection is based on an assessment of the data, whereas wrapper feature selection uses a
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machine learning method on a subset of the data.48 Below is a review of a couple of filter based
feature selectors.
2.5.1

Relief
The Relief feature selector was proposed by Kira and Rendall.60 It performs feature

ranking by choosing an instance at random and comparing the features to a random nearest
neighbor. Near hits and near misses are used to update weights with the formula:
*

WD = WD − diff xD , near-hit D

+ diff xD , near-missD

*

Kononenko61 extended Relief creating Relief-f. The new version could now deal with
noisy, incomplete, and multi-class data sets. For multi-class data sets the near misses were
averaged from each different class. Robnik-Šikonja and Kononenko62 further extended Relief to
handle regression. Regression is implemented not using the class, which is continuous for near
misses, but instead using the relative distance between the predicted classes of two instances. As
the distance increases the influence of other instances decreases exponentially.
2.5.2

Correlation-based Feature Selection (CFS)
The goal of Correlation-based Feature Selection63 is to find features that correlate to the

class but are not correlated to each other. The feature subset evaluation function is
MN =

O$PQ
O + O(O + 1)$QQ

where MN is the merit of subset S containing k features and $PQ is the mean feature-class
correlation and $QQ is the average feature-feature inter-correlation. The Weka implementation
discretizes attributes of nominal classes.
2.5.3

Test –Retest
In “Test-Retest Reproducibility Analysis of Lung CT Image Features” Balagurunathan et

al. compared features from scans that were fifteen minutes apart.64 This analysis was designed to
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find features that were stable and wouldn’t change from small differences between the two scans.
The tumors were segmented both manually by a radiologist and with a single click region
growing ensemble approach. Features were reported that met a concordance correlation
coefficient cutoff of 0.85, 0.90, and 0.95.
2.6

Metrics
Accuracy, or success rate, is the number of correct examples (true positives and true

negatives) over the total.49 It is the percent correct. It is a point on the receiver operating
characteristic (ROC) curve. ROC curves plot the false positive rate on the x-axis and the true
positive rate on the y-axis for, generally, the smallest class. This shows the trade offs between
false positives and true positives. The AUC or area under the receiver operating characteristic
curve reduces this plot to a single measure. It is problematic for evaluating machine learning
models, as one model might outperform another at a given point on the curve. However, it is
popular in the medical literature. The Wilcoxon signed-rank test measures if two populations
have the same mean.65 Pairs are ranked ordered and then their difference is compared. The null
hypothesis is more likely if the difference is close to zero. True positive, TP, is the number of
cases that were predicted positive and are actually positive. True negative, TN, is the number of
cases predicted negative that are actually negative. False positive, FP, is the number whose
prediction is positive but the case is negative. False negative, FN, is when the prediction is
negative but the case was positive. An F-measure 48 is
2 ∗ UV
2 ∗ UV + WV + WX
Sensitivity is the number of people with a positive test result, who are in the true positives.
Specificity is the proportion of people without a disease who have a negative result, 1-false
positive.
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A dice coefficient can be used to measure how well a segmentation compares to another
segmentation. Originally developed by Lee Dice to compare the degree two different species
overlap in ecological studies, the dice coefficient has been adapted for comparing the overlap of
pixels in two segmentations. If Y is the number of pixels of segmentation A and Z is the number
of pixels of segmentation B and ℎ is the number of pixels in the intersection of Y and Z then the
amount of association is
2ℎ
Y+Z
While the dice coefficient is useful for comparing two segmentations there is no ground truth for
lung nodule segmentations. A radiologist’s segmentation can be used or the intersection of
segmentations by multiple radiologists, but there is no absolute answer at the pixel level as to
what should and should not be segmented.
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CHAPTER 3: METHODS1
3.1

Data Sets
In this section, we discuss the data sets as well as the methods of image pre-

preprocessing, segmentation, and feature extraction. Descriptions of the features are also given.
The workflow we used to develop predictive models is represented in Figure 3.1 and is based on
work by Kumar et al..14
3.1.1

Survival Prediction Data Set
The data set used for predicting survival consisted of de-identified CT-scan images from

the Moffitt Cancer Center, Tampa. The images are in the DICOM (Digital Imaging and
Communications in Medicine) format. The data set consists of patients with tumor types of
Adenocarcinoma

and

Squamous-cell

Carcinoma.

This

dissertation

focuses

on

the

adenocarcinoma patients. CT-scans of 81 adenocarcinoma patients were used for survival time
analysis. The slice thickness of the acquired CT-images ranged from 2.5mm to 6mm with an
average thickness of 4.75mm. There were 32 cases in stage one, 20 in stage two, 25 in stage
three, and 4 cases in stage four. The mean survival time was 879 days.
The adenocarcinoma cases were divided into the upper and lower quartiles of survival.
The lower quartile consisted of 20 cases surviving from 103 to 498 days with an average survival
of 288 days. The upper quartile consisted of 20 cases surviving from 1351 to 2163 days with an

1A

version of these methods was previously published in two papers.
Hawkins SH, Korecki JN, Balagurunathan Y, et al. Predicting Outcomes of Nonsmall Cell Lung Cancer Using CT
Image Features. IEEE Access. 2014;2:1418-1426.
Hawkins S, Wang H, Liu Y, et al. Predicting Malignant Nodules from Screening CT Scans. Journal of Thoracic
Oncology. 2016;11(12):2120-2128. See Appendix A for permissions.
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average survival of 1569 days. These two classes were chosen in the expectation that their image
features would be the easiest to differentiate, provide some information on the possibilities, and
the training set is balanced.
The class distribution of survival time is as follows:

3.1.2

•

patients with a survival time in the highest quartile [Class1] = 20

•

patients with a survival time in the lowest quartile [Class – 1] = 20.

NLST Study Population for Malignancy Prediction
Data and images from the NLST were accessed through the NCI Cancer Data Access

System.66 The study design and main findings of the NLST have been described well.11 Briefly,
53,454 current or former smokers between 55 and 74 years of age were enrolled at 33 U.S
medical centers.
The participants were randomly assigned to the LDCT-arm (26,722 subjects) or CXRarm and asked to undergo a baseline and two annual follow-up screenings. CT images were
downloaded and a trained radiologist (H.W.) identified the nodules of interest and ensured
correct matching across annual scans.
3.1.2.1 Patients with SDLC and Nodule-Positive/Cancer-Free Participants
As described in Schabath et al.,10 we restructured the entire CT arm of the NLST
according to screening histories. Based on the NLST protocol, a positive screen was defined as
non-calcified nodule ≥ 4 mm in the axial plane or, less commonly, other abnormalities such as
adenopathy or pleural effusion. Six different screen-detected lung cancer patient cohorts were
defined based on specific sequences of screening results.
For this analysis, we focused on two screen-detected lung cancer (SDLC) patient cohorts
described in Figure 3.2. Both patient groups had baseline (T0) positive screens not associated
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with a lung cancer diagnosis. Individuals in the SDLC Cohort 1 had a screen-detected lung
cancer at the first follow-up screen (T1); SDLC 2 had positive screens at T0 and T1 and a screendetected lung cancer at the second follow-up screen (T2), which was approximately two years
after the baseline screen. Complications with segmentation as described in Table 3.1 led to there
being 85 patients each in SDLC1 and SDLC2.
To compare incidence lung cancer cases to cancer-free (controls) screening participants,
we identified two cancer-free cohorts with benign pulmonary nodules [bPN] that were frequency
matched 2:1 to the SDLCs on demographic characteristics and risk factors (i.e., age [± 5 years],
sex, smoking status, and pack-years smoked [± 5 pack-years]). bPN cohorts -1 and -2 contained
208 and 184 subjects, respectively. Of these, 176 nodules from bPN Cohort 1 and 152 nodules
from bPN Cohort 2 were successfully segmented and hence, available for subsequent radiomic
feature extraction.
Segmentation complications include calcification, or the nodule being attached to the
pleural wall (Table 3.1). Some of these challenges with spiculation and semi-solid nodules can
be overcome when better segmentation algorithms are developed. This nested, matched study
design minimizes the influence of confounders and risk factors between lung cancer patients and
bPN subjects.
Full demographic and clinical descriptors of these cohorts are provided in Table 3.2. The
NLST database-specific patient I.D.’s are provided in Supplemental Table B.1. At baseline, there
was a trend to larger size in the cohort that eventually presented with cancer. The average + SD
of the longest diameters were: 8.06 + 3.45 mm for bPN1 and 8.6 + 3.85 mm for bPN2, and
12.07 + 5.35 mm for SDLC1 and 12.086 + 9.89 for SDLC2. Although these differences were
significant, the multivariate approach increased predictive accuracy.
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3.2

Image Pre-processing
The initial CT segmentation, separating the lung region from the rest of the body, was

done using the algorithm provided in the Lung Tumor Analysis (LuTA) software suite of
Definiens.67 On completion of the lung field segmentation, tumor identification was manually
conducted by one of the radiologists at the H. Lee Moffitt Cancer Center or another person with
expertise in identifying lung tumors. Upon identification, the tumor was segmented out using the
region-growing algorithm developed by Gu et al.39 An expert provided the initial seed point for
the algorithm. The algorithm finds the tumor boundary across the image sequences. This
boundary contains the tumor objects in each slice of the CT-image sequence. Figure 3.3(a) shows
the initial CT image, Figure 3.3(b) shows the segmentation of the lungs, and Figure 3.3(c) shows
the tumor segmentation after region growing.
3.3

Image Feature Extraction and Feature List
In a previous study by Basu et al.,68 a large set of 2D and 3D image features were

evaluated for their effectiveness in building a classifier model to distinguish between
Adenocarcinoma and Squamous-cell Carcinoma. The study concluded that there was no clear
advantage in accuracy between 2D and 3D features, but 3D features simplified constructing
classifiers. Thus for this study, only 3D image features were considered. The image feature
extraction algorithms were written in C++ and the executables were embedded into the LuTA
software. The image feature extraction was done on only the tumor objects after segmentation by
seed growing. The features were normalized from −1 to 1. The major feature types described in
the paper by Balagurunathan et al.69 we evaluated are as follows:
•

Texture features: 125 Laws Features from five one-dimensional kernels, 30 wavelet
features using Daubechies (Coiflet) wavelets calculating energy and entropy.
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•

Geometric features: 13 size and volume descriptions in pixels and millimeters or
centimeters including longest diameter. 12 shape features including compactness,
elliptical fit asymmetry, and density, 14 location features measuring attachment and
distance to the pleural wall.

•

Intensity based features: 8 features of brightness measure statistics in terms of
Hounsfield units (HU), 11 run-length features measuring contiguous grey levels in a
direction, and 6 co-occurrence matrices including contrast, energy, homogeneity,
entropy, mean, and maximum probability. A complete list can be found in
Supplemental Table B.2.

3.3.1

Target Lung Nodule Identification for Malignancy Prediction
Two radiologists reviewed all CT images at both the lung window setting (width, 1500

HU; level, -600 HU) and mediastinal window setting (width, 350 HU; level, 40 HU). The
identification of cancerous nodules in SDLC cohorts was based on the tables provided by the
NLST with information about the location, size, and histology for those that were resected.
Nodule location wasn’t always available for bPN cohorts. In these cases, the head
radiologist, Ying Liu, identified the suspicious 4-12 mm diameter IPN using prior experience.
For those cases with multiple lung nodules, any nodule with diameter of more than 4 mm in a
lung window setting was identified. The largest nodule at time 0 was used for feature extraction
and followed through time. Patients diagnosed with cancer at T1 or T2 were placed into separate
cohorts based on their screening history (Figure 3.2) and their baseline T0 scans were analyzed.
Table 3.3, shows 270 prevalent cases of cancer at the first screen, and 196 SDLCs were
identified following a prior positive scan, compared to 125 SDLCs following nodule-negative
screens, and 44 interval cases diagnosed incidentally before the next screening.10
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3.3.2

Segmentation
Slice numbers of cancerous nodules were provided by NLST and reviewed by

radiologists, Ying Liu and Qian Li, who provided additional anatomical locations for use during
segmentation. Nodules were segmented in 3D with our single-click ensemble segmentation
approach,39 running on a LuTA platform (Definiens, Munich Germany). NLST provided up to
three reconstructions for each time point. The reconstruction chosen by scanner type is found in
Table 3.4. Using an automated segmentation algorithm reduces intra-observer variations;
however relying on a radiologist to find the nodules means there is inter-observer variation.
3.3.3

Features
There were 219 3-D image features extracted from the baseline scan. A challenge for

high-dimensional feature data is over-fitting by having too many features and too few subjects.
Hence, there is a need to prioritize features that: 1) aren’t redundant, 2) have a large inter-subject
biological range, and 3) are stable. In prior work, we studied stability of quantitative features
under repeated (“coffee break”) scans and found some of the stable features are prognostic and
predictive.64,69 The features are listed in Supplemental Table B.3.
3.3.4

Classifier Modeling
WEKA49 was used to build and test classifiers. We compared J48, JRIP, Naïve Bayes,

support vector machines (SVM), and Random Forest(s). J48 is a decision tree classifier.46 The
decision tree was pruned to make it smaller and more generalizable. The confidence factor for
pruning the decision tree was set to 0.25 and the minimum number of cases per leaf was set to 2.
JRIP is a rule learner.54
We used 3 folds, a minimum weight for instances in a rule set to 2.0, 2 optimization runs
and a seed of 1 for splitting data into growing and pruning sets.

30

Naïve Bayes53 is a probabilistic

classifier. The classifier labeled Naïve Bayes53 in Weka49 was used for this work. Support vector
machines30 project the data into a multi-dimensional space to separate classes with a hyper plane.
We used libSVM as our implementation of support vector machines.56 Both linear and radial
basis function kernels were used in building a support vector machine. Cost and gamma
parameters were tuned on training data with a grid search.
The random forests classifier is an ensemble classifier that produces multiple decision
trees. The number of decision trees used was 200.70 Each node in the tree used the best feature of
log 2 the total number of features chosen randomly. When doing cross validation experiments,
two filter feature selection methods were run per fold before classification: Relief-f60-62 and
correlation-based feature subset selection (CFS)63. Relief-f used a ranker search method. CFS
used a greedy stepwise search method.
3.4

Feature Subsets
Computed image features can have a high correlation with each other. This property

combined with the fact that the number of features available to us was much greater than the
number of examples, required the investigation of feature selection techniques to improve
classification accuracy.
Feature selection was done per fold during training. Leave-one-out cross validation
(LOO) was conducted on the data for survival prediction. For malignancy prediction 10-fold
cross validation and as well as separate training and testing sets were used. In addition to feature
selection, some of the classifiers’ models do implicit feature selection. For instance, the decision
tree and rule based classifiers subselect features. Also, support vector machines weight features.
However, Naïve Bayes uses all provided features for classification of the test set. All of
classifiers explore all of the features to build models on the training set.
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3.4.1

All Features
This group includes all 219-image features. No feature selection was performed, thus

providing a baseline for the effectiveness of the feature selection techniques.
3.4.2

Relief-f
The Relief-F algorithm60-62 is a feature evaluator that compares an instance’s feature

value to the nearest neighbor of both the same and opposite classes. We used a seed of 1, 10
nearest neighbors, and a ranker search. In this work, Relief-F was used to assign ranks to each
individual feature. We used the top five and ten features found by the algorithm. Table 3.5 shows
the top features when predicting survival. The top ranked features measure tumor attachment to
the wall of the lung.
3.4.3

Correlation Based Feature Selection
Correlation based Feature Selection (CFS) searches for features that correlate to a class

but do not correlate with each other. The implementation used was found in WEKA49 and
utilized local prediction. We used a greedy stepwise forward search, which generated rankings.
CFS discretizes attributes for nominal classes.
The features chosen are shown in Table 3.6. We can see that CFS prefers texture features
with a few shape features when compared to the choices of Relief-F. Relief-F focuses on pleural
wall attachment type features.
3.4.4

Test-retest
Test-retest features were determined by comparing the stability of features generated

after two different scans of the same patient fifteen minutes apart.69 If a feature is repeatable then
the two subsequent scans should yield a similar value. The tumor was segmented both manually
by a radiologist and with a single click ensemble approach. Different thresholds of correlation
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were used. Attributes were kept that had a test-retest correlation measured by a concordance
correlation coefficient (CCC) of above 0.85, 0.90, and 0.95.
At each correlation threshold different attributes were found using the manual and
ensemble segmentation methods as well as the intersection of both. The 23 features found to be
stable at a CCC of 0.95 for both manual and ensemble segmentations on the RIDER data set are
shown in Supplemental Table B.3. The 37 features found to be stable at a CCC of 0.95 for both
manual and ensemble segmentations on the NLST data set Cohort 1 time 0 are shown in
Supplemental Table B.4.
3.5

Chapter 3 Tables and Figures

Table 3.1: Common segmentation complications.
Complication
Description
Nodule attached to lung wall
Often the lung field preprocessing will identify any nodules
attached to the lung wall as body tissue
GGO

Semisolid Nodules

Inflammation / Scar tissue

Contains air

Spiculation

Between two lobes

Ground glass opacity nodules will segment incorrectly
depending on the intensity of the surrounding tissue. In
some cases the “click and grow” will yield no results.
(Error Message: Area too Dark)
When selecting a seed point in tissue composed of varied
intensities (GGO + Solid) Definiens segmentation software
will sometimes select the entire area of interest while other
times only selecting the solids, leaving out the GGO
When selecting a GGO the “click and grow” will lock onto
nearby inflammation with brighter intensity. When selecting
a solid nodule the “click and grow” will lock onto nearby
scar tissue with brighter intensity.
If a larger nodule has a dark center the “click and grow”
routine will try to segment it out but the result is usually
quite incorrect; removing tissue that should be included.
Generally the more highly spiculated nodules will present
more difficulty, and will have a greater chance of having
nearby bronchi included
A nodule can sometimes attach itself to a fissure line
between two lobes, allowing it to “move” more than nodules
normally do when scrolling through a series.
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Table 3.1 (Continued)
Bronchial Tree

If the bronchial tree is anywhere near the tumor nodule it
is almost always included when growing the ROI
“Independent” nodules too close Two independent nodules at T0 can intersect later at T2
and be mostly impossible to differentiate.
Bone/ Calcification
If nodule contains a calcification or is near a bone and
that tissue is included, the features can be highly skewed
by even a pixel or two.

Table 3.2: Demographics and clinical characteristics of NLST cohort cases.
Lung Cancer
Nodule-Positive
Characteristic
Cases
Controls (N = 328)
(N = 170)
Age, mean (SD)
Sex, N (%)
Male
Female

P-value1

63.7 (5.11)

63.5 (5.1)

0.66

94 (55.3)
76 (44.7)

192 (58.5)
136 (41.5)

0.28

161 (94.7)
9 (5.3)

315 (96.0)
13 (4.0)

0.49

0 (0.0)
170 (100.0)

2 (0.6)
326 (99.4)

0.55

89 (53.4)
81 (47.6)

175 (53.4)
153 (46.6)

0.85

Pack-Years Smoked, mean (SD)
Current smokers
Former smokers

63.2 (25.8)
64.5 (27.6)

62.0 (21.3)
63.7 (26.8)

0.69
0.83

Self-Reported History of COPD, N
(%)
Yes
No

13 (7.6)
157 (92.4)

19 (5.8)
309 (94.2)

0.44

FH of Lung Cancer, N (%)
Yes
No

41 (24.1)
129 (75.9)

56 (17.1)
272 (82.9)

0.07

Race, N (%)
White
Black, Asian, Other
Ethnicity, N (%)
Hispanic or Latino
Neither Hispanic/Latino and
Unknown
Smoking, N (%)
Current
Former

Stage, N (%)
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Table 3.2 (Continued)
I
II
III
IV
Carcinoid, Unknown

117 (68.8)
12 (7.1)
21 (12.3)
18 (10.6)
2 (1.2)

------

--

Histology, N (%)
Adenocarcinoma
108 (63.5)
-Squamous cell carcinoma
38 (22.4)
-Other, NOS, Unknown
24 (14.1)
--Abbreviations: COPD = chronic obstructive pulmonary disease; FH = Family history;
1
P-values calculated using Fisher’s exact test for categorical variables, Student’s t-test for
continuous variables
Table 3.3: NLST cancer-diagnosed cohorts description.
Number
Cohort
Cancer Diagnosed:
Patients
Prevalent
270
At first screen
T0 Interval
18
Following 1 negative screen, prior to 2nd screen
T1 Interval
10
Following 2 negative screens, prior to 3rd screen
T2 Interval
16
Following 3 negative screens
nd
Screen-detected 1
104
At 2 screen following 1 nodule-positive screen
Screen-detected 2
92
At 3rd screen following 2 nodule-positive screens
Screen-detected 3
62
At 2nd screen following 1 negative screen
Screen-detected 4
63
At 3rd screen following 2 negative screens
Table 3.4: Scanner type and reconstruction kernels.
GE
Standard
SIEMENS
B30f
PHILIPS
C
TOSHIBA-CHOICE 1
FC01
TOSHIBA-CHOICE 2
FC10

Lung/Bone
B50f
D
FC30
FC51

Table 3.5: Features chosen to predict survival by Relief-f feature selection from all of the
available features in a leave one out cross validation. Count is how many times the feature was
chosen with the maximum being 40, which is once in every fold. Feature name identifies the
feature.69
Feature Selection
Count
Feature Name
Top 5 Relief-f
40
X8d_3D_Ratio_Free_To_Attached
Top 5 Relief-f
40
X8a_3D_Is_Attached_To_Pleural_Wall
Top 5 Relief-f
40
X8c_3D_Relative_Border_To_PleuralWall
Top 5 Relief-f
40
X8b_3D_Relative_Border_To_Lung
Top 5 Relief-f
40
X3D.Wavelet.decomposition...P1.L2.C14.Layer.1
Top 10 Relief-f
40
X8d_3D_Ratio_Free_To_Attached
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Table 3.5 (Continued)
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f
Top 10 Relief-f

40
40
40
40
40
39
31
21
5
13
11
7
8
2
2
2
4
8
3
2
1
1

X8a_3D_Is_Attached_To_Pleural_Wall
X8c_3D_Relative_Border_To_PleuralWall
X8b_3D_Relative_Border_To_Lung
X3D.Wavelet.decomposition...P1.L2.C14.Layer.1
X3D.Wavelet.decomposition...P1.L2.C10.Layer.1
X3D.Laws.features..E5.S5.R5.Layer.1
X3D.Laws.features..W5.W5.L5.Layer.1
X3D.Laws.features..L5.S5.W5.Layer.1
X3D.Wavelet.decomposition...P1.L2.C9.Layer.1
avgLRE
avgSRE
X3D.Laws.features..L5.L5.S5.Layer.1
X3D.Laws.features..W5.E5.L5.Layer.1
X3D.Laws.features..S5.S5.E5.Layer.1
X3D.Laws.features..W5.S5.L5.Layer.1
X3D.Wavelet.decomposition...P1.L2.C11.Layer.1
X3D.Laws.features..S5.S5.W5.Layer.1
X3D.Laws.features..S5.L5.E5.Layer.1
X5a_3D_MacSpic_NumberOf
Histogram.ENERGY.Layer.1
X3D.Laws.features..R5.E5.L5.Layer.1
X3D.Laws.features..E5.S5.W5.Layer.1

Table 3.6: Features chosen to predict survival by CFS feature selection from all of the available
features in a leave one out cross validation. Count is how many times the feature was chosen
with the maximum being 40, which is once in every fold. Feature name identifies the feature.69
Feature Selection
Count
Feature Name
Top 5 CFS
40
X3D.Laws.features..W5.S5.R5.Layer.1
Top 5 CFS
40
X3D.Laws.features..W5.S5.W5.Layer.1
Top 5 CFS
13
X3D.Laws.features..R5.S5.S5.Layer.1
Top 5 CFS
13
X3D.Laws.features..S5.S5.W5.Layer.1
Top 5 CFS
14
X3D.Laws.features..W5.S5.S5.Layer.1
Top 5 CFS
28
Longest.Diameter..mm.
Top 5 CFS
26
Short.Axis...Longest.Diameter..mm..
Top 5 CFS
24
Short.Axis..mm.
Top 5 CFS
1
X3D.Laws.features..S5.S5.R5.Layer.1
Top 5 CFS
1
X3D.Wavelet.decomposition...P1.L2.C4.Layer.1
Top 10 CFS
40
X3D.Laws.features..W5.S5.R5.Layer.1
Top 10 CFS
40
X3D.Laws.features..W5.S5.W5.Layer.1
Top 10 CFS
13
X3D.Laws.features..R5.S5.S5.Layer.1
Top 10 CFS
13
X3D.Laws.features..S5.S5.W5.Layer.1
Top 10 CFS
14
X3D.Laws.features..W5.S5.S5.Layer.1
Top 10 CFS
40
Longest.Diameter..mm.
Top 10 CFS
40
Short.Axis...Longest.Diameter..mm..
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Table 3.6 (Continued)
Top 10 CFS
Top 10 CFS
Top 10 CFS
Top 10 CFS
Top 10 CFS
Top 10 CFS
Top 10 CFS
Top 10 CFS

CT-Scan
Image

Lung-Field
Segmented Image
!
Image
Pre-processing

40
40
40
28
26
24
1
1

Short.Axis..mm.
Mean..HU.
StdDev..HU.
Volume..cm..
X5a_3D_MacSpic_NumberOf
X8a_3D_Is_Attached_To_Pleural_Wall
X3D.Laws.features..S5.S5.R5.Layer.1
X3D.Wavelet.decomposition...P1.L2.C4.Layer.1

3D Segmented Tumor
Object
Tumor
Identification and
Segmentation

Image Feature
Data and Class

Predictive
Model

Classification
Results

Feature
Extraction

Figure 3.1: Schematic representation of the workflow involved in preparing data for predictive
models. For training all the labeled data is provided and a model built. For testing, the figure
above serves.

Figure 3.2: Flowchart of cohorts. Both cohorts 1 and Cohort 2 had a nodule-positive/cancernegative screen at time 0 (T0). Cohort 1 had a nodule-positive screen at time 1 (T1), with a
screen-detected lung cancer diagnosed in 104 of the cohort members. These individuals were
demographically matched to subjects with benign pulmonary nodules (bPNs) and the same
screening history. Of the 208 bPNs identified at T1, 176 were successfully segmented. Cohort 2
had a nodule-positive/cancer-negative screen at T1, followed by a nodule-positive screen at time
2 (T2), with 92 cohort members having screen-detected lung cancer. These individuals were
demographically matched to 184 subjects with bPNs, 152 of which were successfully segmented.
Segmentation errors are presented in Table 3.1.
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Figure 3.3: Sample CT-image slice. (a) Initial CT image. (b) Lung segmentation. (c) Tumor
segmentation.

38

CHAPTER 4: RESULTS AND CONCLUSIONS2
4.1

Predicting Survival Results
Table 4.1 represents the results with the best accuracy and area under the receiver

operating curve from a leave- one-out analysis using each classifier. With 40 examples, leaveone-out cross validation is performed by using each subset of 39 examples to do feature selection
and build a model using the specified classifier, which is tested on the single held out example.
Finally, the accuracy on each held out example is averaged to find the final leave-one-out
accuracy. The highest classification accuracy was 77.5% and was obtained with the decision tree
classifier using the top 5 features found by Relief-f.
The confusion matrix for this result can be found in Table 4.2. The highest AUC was
with 10 features, chosen by Relief-f at 0.732 for decision trees. For both rule learners and the
decision trees there were often few points on the curve. All feature selection was done per fold.
CFS had an occasional failure selecting test-retest features and those results are omitted. Also,
results that are below 60% accuracy are not listed in Tables 4.3-4.6.
Tables 4.3-4.6 show the results of doing feature selection on the ‘‘stable and
informative’’ features from test-retest for the classifiers used here. In these tables we see that
while the features selected in the test-retest data sets can be subselected to provide good
classifiers, they did not result in the most accurate ones. The data set they come from was more

2

A version of these results was previously published in two papers.
Hawkins SH, Korecki JN, Balagurunathan Y, et al. Predicting Outcomes of Nonsmall Cell Lung Cancer Using CT
Image Features. IEEE Access. 2014;2:1418-1426.
Hawkins S, Wang H, Liu Y, et al. Predicting Malignant Nodules from Screening CT Scans. Journal of Thoracic
Oncology. 2016;11(12):2120-2128. See Appendix A for permissions.
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homogenous in scanner type and parameters. Our data set has a different field of view for every
patient and different slice thicknesses, as well as different scanners.
Figure 4.1 shows the Kaplan-Meier curve of the survival of the two predicted classes
using our best classifier, a decision tree with five features selected using Relief-f. With a p of
0.0219 we reject the null hypothesis that the groups are the same. Thus, the predicted classes are
distinct from one another when predicting survival groups. Table 4.7 shows the results when
training with only volume as a feature. This feature can be useful for differentiating benign from
malignant nodules. Here, its accuracy is too low to be useful.
4.2

Predicting Survival – Conclusions
This is the first study we know of to examine the use of image features from CT scans at

the time of diagnosis to predict survival time on a heterogeneous data set. The accuracy of 77.5%
is promising and is the highest known accuracy for this problem. This result, using five features
chosen with Relief-f, was well above what we were able to achieve using volume alone, which
had an accuracy of 45%. The image features from the CT scans may represent phenotypes
capable of allowing more accurate predictions than can be made by human analysis alone. The
variability of the imaging parameters is a major concern when developing predictive models
using, predominantly, image features. If the same field of view and slice thickness were used for
all cases, then precision could increase. Clearly, future work requires new stable image features
and perhaps an approach using an ensemble of classifiers in which different subsets of features
may further improve the accuracy of survival prediction.
4.3

Predicting Malignancy Results
We test the hypothesis that radiomic analyses of screening CTs at baseline can accurately

predict which IPNs will subsequently develop into clinical cancers. The workflow of our study is
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presented in Figure 4.2. According to NCCN71 and ACR13 guidelines, the method of choice to
distinguish cancerous from benign nodules is to measure nodule growth following a subsequent
screening session after 7-12 months: those with significant growth, 1.5mm or greater13, are
classified as cancerous. Figure 4.3 presents two nodules at baseline and after a subsequent 1-year
follow-up screen. Notably, there was nothing obvious to distinguish the benign (upper) from
cancerous (lower) IPNs at baseline. Hence, they were both characterized as IPNs in the T0
baseline screen. The radiomics features show a few of the most divergent measures, including
relative volume of air spaces and mean attenuation. Notably, baseline volume was larger in the
benign nodule in this case.
4.3.1

Feature Stability
We prioritized a set of features from the RIDER data set, which consisted of two non-

enhanced CT scans of the same patients taken 15 minutes apart with the same scanner settings.
From these analyses, 23 features (Table 4.8) exhibited a concordance correlation coefficient
(CCC) of > 0.95.64,69 The most stable feature category contained nodule size descriptors, where
84% of the features showed concordance > 0.95. Texture features demonstrated lower levels of
concordance due to their high dependence on the CT attenuations. Scanner parameter settings
such as field of view, which affects pixel size, also affect textures.
A histogram of the pixel sizes for each of our cohorts is provided in Figure 4.4, showing
that there was a large amount of variability in the data sets. While such variability may not
adversely affect a radiologists’ ability to provide qualitative assessment, it will likely affect the
ability to extract quantitative radiomic data.
Further, although the protocol specified a slice thickness of 2.0 mm, it can be seen in
Figure 4.5 that the majority were 2.5 mm and above, which also may impact the extraction of
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radiomic data. Non-standardized acquisitions are one known limitation in large multi-center
trials like the NLST. In radiomics, all these variations add to feature description noise and
influence prediction accuracy. Re-interpolation of the data to a fixed voxel size is possible, but
generates noise that cannot be compensated1.
4.3.2

Classifier Models
As presented in Table 4.9 the best accuracy for predicting development of cancer one

year hence (at T1) using baseline scans was 80.1% (AUC = 0.83; FPR = 9%) using a random
forests classifier with RIDER prioritized features.72 We used the Wilcoxon signed-rank test73 on
the results of thirty 10-fold cross validations using the best volume classifier and best all feature
classifier.
Significance was found at the 0.01 level for our full feature approach with the top
classifiers compared to volume for both accuracy and AUC. However, we did try other tests such
as the 5x2 fold cross validation followed by an F-test,74 finding significance at the 0.05 level for
only a subset of random seeds. We believe with more data our approach will always be
statistically significantly better than volume. Table 4.10 shows full results for Cohort 1. For
Cohort 2 the best feature selection/classifier pair shows a top accuracy of 78.7% (AUC = 0.75;
FPR = 11%) for predicting development of cancer 2 years hence (at T2). This accuracy was
achieved with support vector machines using a radial basis function kernel with RIDERprioritized features and feature selection with Relief-f to find the 10 best features. Using
Wilcoxon’s signed-rank test73 on 30 10-fold cross validations showed this result to be better than
volume, which had an accuracy of 71.4%, at the 0.01 level. Full results for Cohort 2 are in Table
4.11. It is understandable that a prediction further into the future in Cohort 2 is not as accurate as
Cohort 1.
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An alternative approach to cross validation is to use one cohort for training and the other
for testing. Table 4.12 shows the accuracy when training on SDLC and bPN T1 cohorts and
testing on SDLC and bPN T2 cohorts. In this case, the best features were RIDER prioritized
further sub-selected with Relief-f. These features were then used to build a random forests
classifier and the classifier was applied to the previously unseen Cohort 2, which yielded a top
accuracy of 76.79% (AUC = 0.81; FPR = 18%). This relatively reduced accuracy is expected
because the biology’s of cancers presenting 1 or 2 years hence are likely different. Using
bagging51 to generate 30 training sets a Wilcoxon test73 showed significance over using volume
alone with the top classifiers for AUC at the 0.01 level. With volume alone, using a JRIP
classifier yielded an accuracy of 72.15%. Full results are presented in Table 4.12.
4.3.3

Solidity
There were 58 nodules that were ground glass in appearance, 41 nodules that were semi-

solid, and 338 that were solid. Some nodules could not be scored. For a full break down see
Table 4.13. Across cohorts, 24 ground glass nodules became cancerous, 27 semi-solid nodules
became cancerous, and 85 solid nodules became cancerous. One of the limitations of this study is
that the 97 nodules that were not solid may take longer than the study period to present as cancer.
Kobayashi and Mitsudomi found that 20% of ground glass lung nodules and 40% of semi-solid
nodules grow slowly while others remain unchanged for years.75
4.3.4

Risk Score
The Lung Imaging Reporting and Data System (Lung-RADS) was developed by the

American College of Radiology to standardize the screening of CT lung cancer images13 into
categories from benign to cancer. We performed Lung-RADS categorization on T0 images from
58 pre-cancers and 127 benign nodules from SDLC-2 and bPN-2, respectively. Categories 3 and
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below were labeled as benign and categories 4A and 4B as malignant. The accuracy of lungRADS in predicting the subsequent development of cancer was 71.4% (Table 4.14). Another risk
score by McWilliams et al. (Brock University cancer prediction equation) utilizes age, sex,
family history of cancer, presence of visually detected emphysema, nodule size, solidity, nodule
location, number of nodules, and spiculation to generate a probability of cancer.20 In the
McWilliams et al. model, 5% risk is a low probability of developing cancer, intermediate is a 5%
to 10% risk, and high is greater than 10%.
We applied this model to the same Cohort 2 data that were scored for Lung-RADS. We
labeled the first two groups as non-cancer and greater than 10% as cancer. The accuracy of this
model was 78.9% (Table 4.14). To extend our radiomics model, we generated a risk score by
categorizing individuals based on their probability of belonging to the malignant or benign
group. In our case, we separated low, intermediate low, intermediate high and high risk as
quartiles. The results using a random forests classifier on the same data set are shown in Table
4.14.
As shown, the radiomics approach performed very well for extreme phenotypes, with
accuracies of 92% and 93% for predicting high and low risk, respectively. Although results in
the intermediate groups were more equivocal, at 63-68%, the overall accuracy of automatically
extracted features was 80.0%, compared to McWilliams, 78.9%, and Lung-RADS 71.4%. We
also compared the radiomics approach to using volume as the only feature, which had an
accuracy of 71.8%. Using McNemar’s test,76 the radiomics result is significantly better than
Lung-RADS, two-tailed p=0.0177, and better than classification with the same models using
volume as the only feature, two-tailed p=0.025, but not significantly better than McWilliams,
two-tailed p=0.8383. However, the radiomics model has the added benefit to radiologists of
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being automated after the nodule has been found for segmentation for a given nodule. Figure 4.6
shows the ROC curves for the McWilliams approach, which has an AUC of 0.67, volume, which
has an AUC of 0.74, and the radiomics scoring schema, which has an AUC of 0.87.
4.4

Predicting Malignancy Discussion
The long-term vision for this work is to qualify the application of radiomic biomarkers to

reduce over-diagnosis and over-treatment of screen- and incidentally-detected lung nodules. It
can be envisioned that these radiomics risk scores can be used now to prescribe optimal time for
follow up scans for definitive differential diagnosis. Hence, a subject with a low risk score could
be scanned less often than one with a high score. The current results show that a subset of
radiomic features extracted from indeterminate pulmonary nodules at a baseline CT screening
scan can be used to predict the subsequent occurrence of cancer or non-cancer with an overall
accuracy of 80%.
Importantly, this approach has an accuracy >90% when predicting extreme benign and
malignant phenotypes; classifications that include more than half of the subjects in this study.
Currently, prediction of lung cancer risk in a screening setting is achieved using the LungRADSTM system, which classifies risk of cancer from CT scans based on size, solidity and
location. Lung-RADs was developed for lung cancer screening by the American College of
Radiology, ACR13. Although Lung-RADSTM was not used in the NLST for prospective
structured reporting, it was recently evaluated in a large retrospective study,19 resulting in a
decrease in FPR from 26.6% to 12.8%; hence a significant reduction in the overdiagnosis and
overtreatment. Sensitivity of detecting a cancer was lower for Lung-RADS vs. the NLST (84.9%
vs. 93.5%) and this did not appreciably improve upon subsequent follow-up scans. In
comparison, the radiomics approach herein achieved FPRs of 9% and 11%, sensitivities of 58%
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and 60% and specificities of 91% and 89% at baseline to predict subsequent cancer 1 and 2 years
hence, respectively. The most advanced molecular technique used serum miRNA to achieve a
prediction sensitivity of 87% and specificity of 81%.2 However, most of their sampling was done
at the time of diagnosis (50 of 69), so its ability to predict across time is unknown. It should be
noted that our case-control design has a 2:1 mixture of bPN to SDLC for training, which leads to
a lower FPR, however the training mixture could be changed and so this measurement is
reported.
These results must be tempered by acknowledging the limitations to the current study,
and areas for improvement exist. The biggest limitations to the current study were cohort sizes,
non-standardization of image acquisition, and the lack of clinical or molecular data. Although
there were 26,722 subjects in the LDCT arm of the NLST, only 206 of these subjects developed
screen-detected lung cancers (SDLC) following a nodule-positive screen. Hence, with these
relatively small numbers it is difficult to accommodate co-variates of patient characteristics. We
controlled for these by demographic matching the cohorts under study, but this did not allow for
analysis of the individual subjects with greater granularity. At baseline, there were a total of
6,921 NLST participants who had nodule-positive/cancer-negative screens, with 6,715 having
IPNs that did not develop into lung cancer. Hence, the ratio of non-cancer to eventual-cancer of
an IPN at baseline is ~32:1. In our cohort analyses, we compared non-cancer to eventual-cancer
at a ratio of 2:1 and hence, there was a false discovery bias emanating from the proportionalities
in our study population. While the nested cohort design limits confounding factors, it may also
limit extrapolation to the larger NLST population. Regarding non-standard imaging, although
exams in the NLST were supposed to be reconstructed to a slice thickness of 2.0 mm, the actual
thickness varied from 1 to 5 mm; fields of view (FOV) varied significantly between and within
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patients (Figures 4.4, 4.5); and reconstruction kernels are not comparable between manufacturers
(Table 3.4). These issues limit the potential power of radiomics. A further limitation is the time
required to curate the database, identify the lesions and extract the features. In theory, these
could be reduced if the data curation and nodule identification occurred at the time of the
primary radiology read, the so-called “Radiology Reading Room of the Future.”25 Nonetheless,
even with these caveats, radiomic-based classifier models and risk assessments exhibited
significant power to identify those patients with IPNs at baseline who are most or least, likely to
develop cancer. Moving forward, features are being qualified based on their sensitivity to
reconstruction kernels and overly sensitive features can be removed during dimensionality
reduction. With very large data sets, these can be parsed as co-variates. While it will be
preferable to acquire all images with standardized fields of view and reconstruction matrices, this
is proving to be impractical. To accommodate inter-subject differences, pixel sizes can be
regularized by interpolation.
To rectify these deficits large databases will be needed. An important opportunity will be
the ACR based Lung Cancer Screening Registry (LCSR) to capture screening metadata. Therein
will be an opportunity to develop a federated, living database of images and radiomic data so that
co-variates and evolving acquisition standards can be accommodated.
4.5

Chapter 4 Tables and Figures

Table 4.1: Summary of the highest survival leave-one-out accuracy and AUC results containing
the feature selection method, number of features, average accuracy, lower quartile accuracy,
upper quartile accuracy, and the area under the receiver operating curve. LQ is lower quartile and
UQ is upper quartile.
Classifier
Features
#
Avg
LQ Accy UQ Accy
AUC
Decision
Top 5 Relief-f
5
77.5 %
65 %
90 %
0.712
Tree
Decision
Top 10 Relief-f
10
70 %
65 %
75 %
0.732
Tree
Rules
All
219
62.5%
65 %
60 %
0.729
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Table 4.1 (Continued)
Rules
All Top 5 Relief-f
Naïve
All Top 10 Relief-f
Bayes
Manual &
Naïve
Ensemble testBayes
retest (.85) Top 5
RF
Manual test-retest
SVM
(.90) Top 10
Relief-f

5

75 %

65 %

85 %

0.661

10

65 %

55 %

75 %

0.52

5

60 %

45 %

75 %

0.64

10

65 %

70 %

60 %

0.65

Table 4.2: Confusion matrix of the top result, 77.5%, using a decision tree classifier with the top
five features chosen using Relief-f.
Actual Short Survival
Actual Long Survival

Predicted Short Survival

Predicted Long Survival

13
2

7
18

Table 4.3: Survival leave-one-out accuracy results doing further feature selection on test-retest
features for decision trees containing the feature selection method, number of features, average
accuracy, lower quartile accuracy, upper quartile accuracy, and the area under the receiver
operating curve.
Classifier Features
#
Avg Accy LQ Accy UQ Accy
AUC
Top 5 Relief-f
5
77.5%
65%
90%
0.712
Top 10 Relief-f
10
70%
65%
75%
0.732
All Top 5 CFS
5
62.5%
95%
30%
0.292
All Top 10 CFS
10
65%
75%
55%
0.552
Manual test-retest (.95)
45
60%
95%
25%
0.271
Manual test-retest (.90) Top
10
67.5%
70%
65%
0.562
10 Relief-f
Manual test-retest (.90) Top
10
60%
70%
50%
0.435
10 CFS
Manual test-retest (.85) Top
Decision
5
62.5%
85%
40%
0.455
5 Relief-f
Tree
Manual test-retest (.85) Top
5
72.5%
95%
50%
0.488
5 CFS
Manual test-retest (.85) Top
10
62.5%
70%
55%
0.51
10 CFS
Ensemble test-retest (.95)
5
65%
100%
30%
0.3
Top 5 CFS
Ensemble test-retest (.95)
10
65%
100%
30%
0.3
Top 10 CFS
Ensemble test-retest (.90)
5
62.5%
95%
30%
0.292
Top 5 CFS
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Table 4.3 (Continued)
Ensemble test-retest (.90)
Top 10 CFS
Ensemble test-retest (.85)
Top 5 CFS
Decision Ensemble test-retest (.85)
Tree
Top 10 CFS
Manual & Ensemble testretest (.90) Top 10 Relief-f
Manual & Ensemble testretest (.85) Top 10 Relief-f

10

65%

75%

55%

0.524

5

62.5%

95%

30%

0.292

10

65%

75%

55%

0.524

10

65%

70%

60%

0.691

10

62.5%

65%

60%

0.68

Table 4.4: Survival leave-one-out accuracy results doing further feature selection on test-retest
features for JRIP containing the feature selection method, number of features, average accuracy,
lower quartile accuracy, upper quartile accuracy, and the area under the receiver operating curve.
Classifier Features
#
Avg Accy LQ Accy UQ Accy
AUC
All
219
62.5%
65%
60%
0.729
All Top 5 Relief-f
5
75%
65%
85%
0.661
All Top 10 Relief-f
10
65%
60%
70%
0.598
Rules
Manual test-retest (.90)
10
62.5%
75%
50%
0.568
Top 10 Relief-f
Manual test-retest (.85)
95
62.5%
75%
50%
0.688
Table 4.5: Survival leave-one-out accuracy results doing further feature selection on test-retest
features for Naïve Bayes containing the feature selection method, number of features, average
accuracy, lower quartile accuracy, upper quartile accuracy, and the area under the receiver
operating curve.
Avg
LQ
UQ
Classifier Features
#
AUC
Accy
Accy
Accy
All Top 5 Relief-f
5
62.5%
45%
80%
0.605
All Top 10 Relief-f 10
65%
55%
75%
0.52
Manual test-retest
(.95) Top 5 Relief5
60%
40%
80%
0.458
f
Manual test-retest
(.90) Top 5 Relief5
60%
45%
75%
0.54
Naïve
f
Bayes
Manual &
Ensemble test5
60%
40%
80%
0.552
retest (.95) Top 5
Relief-f
Manual &
Ensemble test5
60%
45%
75%
0.64
retest (.85) Top 5
RF
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Table 4.6: Survival leave-one-out accuracy results doing further feature selection on test-retest
features for svm containing the feature selection method, number of features, average accuracy,
lower quartile accuracy, upper quartile accuracy, and the area under the receiver operating curve.
LQ
Classifier Features
#
Avg Accy
UQ Accy AUC
Accy
Manual test-retest (.90) Top
10
65%
70%
60%
0.65
10 Relief-f
Manual & Ensemble test5
62.5%
65%
60%
0.625
retest (.90) Top 5 Relief-f
Manual & Ensemble test10
60%
65%
55%
0.6
SVM
retest (.90) Top 10 Relief-f
Manual & Ensemble test5
62.5%
65%
60%
0.625
retest (.85) Top 5 Relief-f
Manual & Ensemble test10
60%
65%
55%
0.6
retest (.85) Top 10 Relief-f
Table 4.7: Survival leave-one-out accuracy results using only volume containing the feature
selection method, number of features, average accuracy, lower quartile accuracy, upper quartile
accuracy, and the area under the receiver operating curve.
Classifier
Features
#
Avg Accy
LQ Accy
UQ Accy
AUC
Decision Tree
Volume
1
45%
40%
50%
0.45
Rules
Volume
1
32.5%
45%
20%
0.223
Naïve Bayes
Volume
1
45%
60%
30%
0.388
SVM
Volume
1
15%
20%
10%
0.15
Table 4.8: Stable feature names found from RIDER experiments.
Feature Name
LongDia
ShortAx-LongDia
ShortAx
Vol-cm
Area-Pxl
Volume-pxl
Num-Pxl
Width-Pxl
Thickness-Pxl
Length-Pxl
Border-Leng-Pxl
9c-3D-Compact
Compactness
Shape-Index
9d-3D-AV-Dist-COG-to-Border
9g-3D-Max-Dist-COG-to-Border
10a-3D-Relat-Vol-Airspaces
Mn-Hu
AvgGLN
AvgRLN
AvgRP
3D-Laws-16
3D-Laws-41

Description
Longest Diameter
Short Axis Longest Diameter
Short Axis
Volume
Area in pixels
Volume In Pixels
Number Of Pixels
Width In Pixels
Thickness In Pixels
Length In Pixels
Border Length In Pixels
Shape (Roundness)
Shape (Roundness)
Shape (Roundness)
Location
Location
Location
Pixel Intensity Histogram
Grey-Level Non-uniformity
Run Length Non-uniformity
Average Run Percentage
Laws Texture
Laws Texture
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Table 4.9: Performance of radiomic based prediction classifier models. The one-year prediction of Cohort 1 obtained an accuracy of
80.12%. The two-year prediction of Cohort 2 obtained an accuracy of 78.78%. Training on cohort one and testing on Cohort 2
obtained and accuracy of 76.79%. The top accuracy using only volume is also listed.
Cross
Validation

Feature
Selection

Number of
Features

Accuracy

AUC

FPR

TPR

TNR

CFS 10

10

76.13%

0.70

0.11

0.5

0.82

CFS 5

5

77.82%

0.72

0.1

0.53

0.9

CFS 10

10

79.47%

0.79

0.08

0.53

0.92

None

23

80.12%

0.83

0.09

0.58

0.91

CFS 10

10

79.4%

0.72

0.08

0.52

0.92

None
CFS 5

1
5

75.56%
76.89%

0.72
0.72

0.18
0.09

0.62
0.52

0.82
0.91

None

23

76.18%

0.72

0.12

0.56

0.88

CFS 10

10

72.88%

0.73

0.08

0.38

0.92

None

23

77.83%

0.83

0.13

0.62

0.87

RF 10

10

78.78%

0.75

0.11

0.6

0.89

None
None
None
CFS 10

1
37
219
10

71.4%
74.68%
72.57%
73.00%

0.66
0.62
0.66
0.63

0.07
0.05
0.09
0.04

0.32
0.38
0.4
0.32

0.93
0.95
0.91
0.96

RF 10

10

76.79%

0.81

0.18

0.67

0.82

RF 10

10

75.53%

0.73

0.19

0.66

0.81

JRIP
Volume
None
1
72.15%
0.63
0.05
0.32
FS – Feature selection,
RIDER Stable– is the intersection of the stable features from manual and ensemble segmentations with CCC > 0.95 on the RIDER data set,
FPR – false positive rate,
TPR – True Positive Rate (Sensitivity),
TNR – True Negative Rate (Specificity).

0.95

Classifier
J48
JRIP

10x10-Fold on
Cohort 1

NB
Random Forest
SVM-Linear
kernel
J48
J48
JRIP

10x10-Fold on
Cohort 2

Train on
Cohort 1 and
Test on Cohort
2

NB
Random Forest
SVM-RBF
kernel
J48
J48
JRIP
NB
Random Forest
SVM-RBF
kernel

Feature
Subset
RIDER
Stable
RIDER
Stable
RIDER
Stable
RIDER
Stable
RIDER
Stable
Volume
All
RIDER
Stable
All
RIDER
Stable
RIDER
Stable
Volume
NLST Stable
All
NLST Stable
RIDER
Stable
RIDER
Stable
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Table 4.10: Percentage accuracy SDLC and bPN Cohort 1 using all 219 image features, RIDER
stable features, and volume alone.
Classifier
FS
All Features
RIDER Stable
Volume
J48
None
71.85
73.24
75.56
J48
RF 5
72.99
71.04
J48
RF 10
71.27
74.98
J48
CFS 5
74.8
76.03
J48
CFS 10
73.15
76.13
JRIP
None
75.94
76.59
75.18
JRIP
RF 5
74.72
74.15
JRIP
RF 10
73.73
75.76
JRIP
CFS 5
75.56
77.82
JRIP
CFS 10
75.38
76.57
NB
None
67.61
79.05
70.23
NB
RF 5
74.3
76.11
NB
RF 10
76.02
78.82
NB
CFS 5
76.95
78.4
NB
CFS 10
76.48
79.47
SVM-Linear
None
76.26
79.24
70.46
SVM-Linear
RF 5
73.95
75.76
SVM-Linear
RF 10
74.57
79.12
SVM-Linear
CFS 5
77.75
79.24
SVM-Linear
CFS 10
77.14
79.4
SVM-RBF
None
77.17
78.66
74.59
SVM-RBF
RF 5
72.92
74.41
SVM-RBF
RF 10
74.14
78.78
SVM-RBF
CFS 5
77.75
78.02
SVM-RBF
CFS 10
76.68
78.52
Random Forest
None
78.47
80.12
70.11
Random Forest
RF 5
68.92
71.23
Random Forest
RF 10
71.69
77.2
Random Forest
CFS 5
74.56
76.01
Random Forest
CFS 10
76.67
77.09
FS – Feature selection, RIDER Stable– is the intersection of the stable features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set.
Table 4.11: Percentage accuracy SDLC and bPN Cohort 2 using all 219 image features, RIDER
stable features, and volume alone.
Classifier
FS
All Features RIDER Stable
Volume
J48
None
73.04
75.34
71.4
J48
RF 5
65.31
70.36
J48
RF 10
68.66
74.59
52

Table 4.11 (Continued)
J48
CFS 5
76.89
68.22
J48
CFS 10
75.77
69.8
JRIP
None
69.78
76.18
70.09
JRIP
RF 5
66.45
68.48
JRIP
RF 10
71.08
75.59
JRIP
CFS 5
74.02
67.33
JRIP
CFS 10
72.9
67
NB
None
70.42
69.36
67.56
NB
RF 5
65.39
47.93
NB
RF 10
65.64
70.59
NB
CFS 5
72.07
69.07
NB
CFS 10
72.88
69.2
SVM-Linear
None
73.38
70.67
66.89
SVM-Linear
RF 5
64.15
66.37
SVM-Linear
RF 10
64.07
68.93
SVM-Linear
CFS 5
69.61
67.17
SVM-Linear
CFS 10
69.14
66.96
SVM-RBF
None
77.26
77.69
69.57
SVM-RBF
RF 5
68.14
72.83
SVM-RBF
RF 10
69.86
78.78
SVM-RBF
CFS 5
71.64
69.74
SVM-RBF
CFS 10
72.06
69.74
Random Forest
None
76.7
77.83
62.53
Random Forest
RF 5
67
67.52
Random Forest
RF 10
69.74
77.61
Random Forest
CFS 5
71.28
67.21
Random Forest
CFS 10
74.79
68.26
FS – Feature selection, RIDER Stable – is the intersection of the stable features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set.
Table 4.12: Percentage accuracy training on Cohort 1 and testing on Cohort 2.
Classifier
FS
All Features RIDER Stable NLST Stable
J48
None
70.04
65.4
74.68
J48
RF 5
59.92
67.09
67.51
J48
RF 10
62.03
72.15
57.38
J48
CFS 5
67.93
70.89
69.62
J48
CFS 10
64.56
70.89
73
JRIP
None
72.57
70.89
70.04
JRIP
RF 5
67.51
67.51
64.56
JRIP
RF 10
60.76
67.09
60.34
JRIP
CFS 5
69.2
67.09
70.89
53

Volume
71.73

72.15

Table 4.12 (Continued)
JRIP
CFS 10
69.62
66.24
70.46
NB
None
68.35
69.62
71.73
67.09
NB
RF 5
68.35
69.62
63.71
NB
RF 10
64.56
71.31
57.38
NB
CFS 5
71.31
72.15
71.31
NB
CFS 10
70.46
69.62
73
SVM-Linear
None
71.73
71.73
68.78
67.93
SVM-Linear
RF 5
67.51
71.31
64.14
SVM-Linear
RF 10
66.67
70.04
65.82
SVM-Linear
CFS 5
70.46
68.35
68.78
SVM-Linear
CFS 10
68.78
67.93
70.04
SVM-RBF
None
71.31
69.2
68.78
68.35
SVM-RBF
RF 5
67.09
68.35
70.04
SVM-RBF
RF 10
67.51
75.53
67.51
SVM-RBF
CFS 5
70.46
67.93
68.35
SVM-RBF
CFS 10
71.31
73.42
67.93
Random Forest
None
71.31
75.53
74.26
68.78
Random Forest
RF 5
65.4
71.31
66.24
Random Forest
RF 10
69.62
76.79
69.62
Random Forest
CFS 5
69.2
68.35
74.68
Random Forest
CFS 10
70.46
64.98
71.31
FS – Feature selection, RIDER Stable– is the intersection of the features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable is
37 features stable across 3 time points for benign tumors.
Table 4.13: Nodule solidity.
Cohort
SDLC 1
bPN 1
SDLC 2
bPN 2

Ground Glass
11
17
13
17

Semi-Solid
19
7
8
7

Solid
48
149
37
104

Table 4.14: Risk scores for three approaches from baseline NLST for predicting subsequent
cancer. Lung-RADS obtained a total accuracy of 71.4%. The McWilliams approach obtained an
accuracy of 78.9%. The radiomic approach obtained an accuracy of 80.0%. The Volume Only
approach obtained an accuracy of 71.8%.
#
#
Model
Category
Total
Malignant Benign
Accuracy
TPR
TNR
Overall
Total
58
127
185
Lung-RADS
(71.4%)

2

32

99
54

131

75.6%

Table 4.14 (Continued)

McWilliams
(78.9%)

Radiomics
(80.0%)

Volume
(71.8%)

3

13

20

33

60.6%

4A

10

7

17

58.8%

4B

3

1

4

75.0%

Total

58

127

185

71.4%

Low

24

98

122

79.7%

Intermediate

7

21

28

75.0%

High

27

8

35

77.1%

Total

58

127

185

78.9%

Low

6

80

86

93.0%

22

38

60

63.3%

17

8

25

68.0%

High

13

1

14

92.9%

Total

58

127

185

80.0%

Low

17

85

102

83.3%

13

20

33

60.6%

5

15

20

25.0%

High

23

7

30

76.6%

Total

58

127

185

71.8%

IntermediateLow
IntermediateHigh

IntermediateLow
IntermediateHigh

22.4%

93.7%

46.5%

93.7%

51.7%

92.9%

48.2%

82.7%

Lung RADS categories include: Benign Appearance and Behavior (2), Probably Benign (3),
and Suspicious (4A, 4B).
McWilliams categories include: Low, Intermediate, and High
Radiomics categories include: Low, Intermediate-Low, Intermediate-High, and High
Volume Only categories include: Low, Intermediate-Low, Intermediate-High, and High
TPR – True Positive Rate (Sensitivity), TNR – True Negative Rate (Specificity)
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Figure 4.1: Kaplan-Meier curve of the predicted survival classes using our best classifier, a
decision tree with five features selected using Relief-f, p = 0.0219.

Figure 4.2: Workflow from image to prediction. Starting with a CT scan, the lungs then nodules
were segmented. Features were extracted and used to build predictive models that predicted
occurrence of cancer or benign nodules in subsequent screens 1 or 2 years hence.
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Figure 4.3: Images of screen-detected lung cancer (SDLC) and benign pulmonary nodules (bPNs) at time 0 (T0) and time 1 (T1). The
top images are from a patient with a bPN in Cohort 1. The bottom images are from a patient with SDLC in Cohort 1. The T0 scans
appear similar to the eye, and growth can clearly be seen on the T1 SDLC scan relative to no growth of the T1 bPN scan. Select
radiomics features from the T0 scans that discriminated the groups are shown in the text boxes. 3D, three-dimensional.
57

(A)

(B)

(C)
(D)
Figure 4.4: Pixel size histograms per cohort. Pixel sizes were calculated for individual scans in
(A) SDLC-1, (B) bPN-1, (C) SDLC-2, and (D) bPN-2 groups, showing a wide range of pixel
sizes from the NLST data.

Figure 4.5: Slice thicknesses. This represents the slice thickness for all scans used in this study.
The majority of cases were of 2.5 mm.
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Figure 4.6: Binary classifier prediction. Receiver operator characteristic (ROC) curves of risk scores for the McWilliams model, our
random forests–based approach, and the volume-only approach are shown (see text for details). The McWilliams model resulted in an
area under the ROC of 0.67 and the volume-only approach provided an area under the curve of 0.74, whereas the radiomics classifier
using random forests resulted in an area under the curve of 0.87. 3D, three-dimensional; NLST, National Lung Screening Trial;
SDLC, screen-detected lung cancer; bPN, benign pulmonary nodules
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CHAPTER 5: CORRECTION
5.1

Problem
There was a problem with feature calculations in Definiens that caused four features to be

computed incorrectly. This was discovered after the paper “Predicting Malignant Nodules from
Screening CT Scans”12 which used the data was published. Hence, this Chapter examines the
problem, correction and change in results. These four features all deal with a nodules distance to
the pleural wall. A nodules distance can vary. The four features are maximum, average, and
minimum distance to the pleural wall, and standard deviation of the distance of the nodule to the
pleural wall. This affected a single case in cohort 2 at time 0. However, the maximum, minimum
and average distances were listed as 10 km, which affects the normalization of the features. The
standard deviation was 0. When these four features were normalized to between -1 and 1, this
case had 1 for the maximum, minimum and average features and all the other cases were very
close to -1 making these features not describe what they were expected to describe. This problem
did not affect the predictions on survival in the paper “Predicting Outcomes of Nonsmall Cell
Lung Cancer Using CT Image Features.”8
5.2

Solution
The solution to fix these features was to list these four features as missing when they

were incorrectly computed (i.e. for this case). Different classifiers will handle this in different,
but appropriate ways. Decision trees split a missing value between paths through the tree,
weighting the value according to the number of training instances taking that branch. The pieces
are recombined using weights when they have reached the leaves.48 Random Forests follow the
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same procedure for missing values as decision trees as they are made up of many decision trees.
Naïve Bayes can just omit missing values.48 For rule based classifiers such as Ripper missing
values can be treated similarly to decision tree with one advantage. Missing values can be treated
as if they didn’t match any tests. This allows an instance containing missing values to be
deferred until tests are available using other attributes.48 For support vector machines, WLSVM
and LIBSVM don’t use missing values and data is stored in a sparse format allowing for many
missing values.56,58
5.3

Updated Results for Predicting Malignancy
Cohort 1 was unaffected. Cohort 2 had one case with 4 features that were miscalculated.

These values were replaced and listed as missing. When training on Cohort 1 and testing on
Cohort 2 the results can be seen in Table 5.1. These results replace Table 4.12. 10x 10-fold cross
validations were also performed on Cohort 2. Table 5.2 replaces Table 4.11. Finally, the
predictions on the subset of Cohort 2 for which Lung-RADS was scored was also recomputed
the results are in the Table 5.3.
5.4

Discussion on Predicting Malignancy Corrections
When training on Cohort 1 and testing on Cohort 2 using updated features the highest

accuracy improves. Using the same classifier and feature selection as before the accuracy goes
from 76.79% (AUC = 0.82) to 77.22% (AUC=0.82). Another classifier however now has a
slightly better accuracy. SVM with an RBF kernel on with the 10 best RIDER stable features
selected with Relief-f has an accuracy of 77.64% (AUC=0.74).

However, this is not a

statistically significantly better result. McNemar’s test76 comparing the two results yields a pvalue of 0.055. The best AUC continues to be 0.82 and remains unchanged from the previous
best.

61

When applying 10x 10-fold cross validation to Cohort 2 the accuracy also improves. The
previous best accuracy was 78.78% (AUC = 0.75) with an SVM classifier using 10 Relief-f
features from the RIDER stable features. The previous best AUC was 0.83 with a Random
Forests classifier using 219 features. The best new accuracy is 79.15% with a support vector
machine with a RBF kernel using NLST stable features. There was no significant improvement
in accuracy with McNemar’s test yielding a p-value of 0.5839. The new best AUC is 0.84 with a
Random Forests classifier using 10 features selected with Relief-f on RIDER stable features..
There was no significant improvement in AUC with a Mann-Whitney U test77 yielding a p-value
of 0.69.
The model built on the subset of Cohort 2 that had been scored for Lung-RADS
previously had an accuracy of 80% (AUC=0.87) using a Random Forests classifier. With the
correction the same classifier has an accuracy of 78.33% (AUC=0.87), but a support vector
machine classifier with an RBF kernel on 36 NSLT Cohort 2 stable features produces an
accuracy of 83.8% (AUC=0.78). However, this increase is also not significant and the difference
has a McNemar’s p-value of 0.3123. The best AUC continues to be 0.87 and remains unchanged
from the previous best. Correcting the calculation for a nodule’s distance to the pleural wall led
to a slight increase in accuracy. While this was the case across the board, none of the increases
were statistically significant at the p=0.05 level.
5.5

Chapter 5 Tables

Table 5.1: Corrected percentage accuracy training on Cohort 1 and testing on Cohort 2.
Classifier
FS
All Features RIDER Stable NLST Stable
Volume
J48
None
70.46
65.82
75.11
71.73
J48
RF 5
59.92
67.09
67.51
J48
RF 10
62.03
74.26
57.38
J48
CFS 5
67.93
70.89
69.62
J48
CFS 10
64.56
70.89
76.37
62

Table 5.1 (Continued)
JRIP
None
72.57
70.89
70.89
JRIP
RF 5
67.51
67.51
64.56
JRIP
RF 10
60.76
67.09
60.34
JRIP
CFS 5
67.93
67.93
70.89
JRIP
CFS 10
69.62
67.51
70.89
NB
None
68.35
70.04
71.31
NB
RF 5
68.35
69.62
63.71
NB
RF 10
64.56
71.73
57.38
NB
CFS 5
71.31
70.89
71.73
NB
CFS 10
70.89
70.46
73
SVM-Linear
None
72.15
70.46
68.78
SVM-Linear
RF 5
67.51
71.31
64.14
SVM-Linear
RF 10
66.67
71.73
65.82
SVM-Linear
CFS 5
69.2
67.93
68.78
SVM-Linear
CFS 10
68.78
68.78
69.62
SVM-RBF
None
71.31
70.04
68.78
SVM-RBF
RF 5
67.09
68.35
70.04
SVM-RBF
RF 10
67.51
77.64
67.51
SVM-RBF
CFS 5
69.62
68.35
68.78
SVM-RBF
CFS 10
71.31
70.04
68.78
Random Forest
None
70.89
75.11
72.57
Random Forest
RF 5
65.4
71.31
66.24
Random Forest
RF 10
69.62
77.22
69.62
Random Forest
CFS 5
70.89
63.71
76.37
Random Forest
CFS 10
71.31
66.24
74.68
FS – Feature selection, RIDER Stable– is the intersection of the features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable
is 37 features stable across 3 time points for benign tumors.

72.15

67.09

67.93

68.35

68.78

Table 5.2: Corrected percentage accuracy SDLC and bPN Cohort 2 using all 219 image features,
RIDER stable features, and volume alone.
Classifier
FS
All
RIDER
NLST
Volume
Features
Stable
Stable
J48
None
73.04
75.34
73.46
71.4
J48
RF 5
64.67
70.37
75.22
J48
RF 10
68.66
74.29
75.18
J48
CFS 5
76.89
68.22
70.05
J48
CFS 10
75.77
69.53
69.98
JRIP
None
69.98
75.97
76.46
70.09
JRIP
RF 5
65.92
67.7
70.6
JRIP
RF 10
70.44
75.89
75.17
63

Table 5.2 (Continued)
JRIP
CFS 5
74.02
67.96
68.11
JRIP
CFS 10
73.06
67.21
69.07
NB
None
70.38
69.62
69.24
67.56
NB
RF 5
65.22
46.37
53.93
NB
RF 10
65.32
70.8
71.95
NB
CFS 5
72.07
69.07
70.55
NB
CFS 10
72.92
69.24
70.17
SVM-Linear
None
73.75
70.89
74.3
66.89
SVM-Linear
RF 5
64.15
65.54
66.52
SVM-Linear
RF 10
64.07
68.93
70.72
SVM-Linear
CFS 5
69.61
67.25
69.16
SVM-Linear
CFS 10
69.14
66.99
68.4
SVM-RBF
None
78.04
78.07
79.15
69.57
SVM-RBF
RF 5
68.38
72.97
73.25
SVM-RBF
RF 10
70.15
78.78
79.03
SVM-RBF
CFS 5
71.64
69.91
70.75
SVM-RBF
CFS 10
72.19
69.44
70.17
Random Forest
None
76.49
77.74
76.68
62.53
Random Forest
RF 5
68.48
68.8
69.28
Random Forest
RF 10
70.17
78.88
76.66
Random Forest
CFS 5
73.58
68.44
68.02
Random Forest
CFS 10
76.39
67.66
70.73
FS – Feature selection, RIDER Stable – is the intersection of the stable features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set.
Table 5.3: Corrected percentage accuracy on Cohort 2 that had a Lung-RADS score
Classifier
FS
All Features RIDER Stable NLST Stable
Volume
J48
None
74.53
78.8
77.22
77.72
J48
RF 5
69.68
74.53
77.84
J48
RF 10
72.87
77.25
82.16
J48
CFS 5
79.47
77.34
76.17
J48
CFS 10
79.36
74.59
76.7
JRIP
None
73.01
74.97
74.59
76.08
JRIP
RF 5
71.87
74.21
70.2
JRIP
RF 10
68.65
80.47
81.55
JRIP
CFS 5
76.23
69.74
73.42
JRIP
CFS 10
71.84
71.32
72.98
NB
None
73.51
75.12
74.56
72.43
NB
RF 5
65.99
61.26
41.73
NB
RF 10
65.5
73.63
77.25
NB
CFS 5
77.19
74.56
75.09
64

Table 5.3 (Continued)
NB
CFS 10
77.75
74.56
74.56
SVM-Linear
None
80.56
75.73
77.92
70.85
SVM-Linear
RF 5
68.65
73.1
70.88
SVM-Linear
RF 10
68.65
75.2
74.59
SVM-Linear
CFS 5
72.98
71.4
71.96
SVM-Linear
CFS 10
75.12
72.46
72.46
SVM-RBF
None
81.02
83.16
83.8
74.56
SVM-RBF
RF 5
73.45
78.39
77.95
SVM-RBF
RF 10
74.01
79.97
83.25
SVM-RBF
CFS 5
75.61
70.85
72.92
SVM-RBF
CFS 10
73.48
72.98
72.43
Random Forest
None
78.33
79.97
80.47
70.38
Random Forest
RF 5
70.85
75.67
72.95
Random Forest
RF 10
75.58
82.22
79.94
Random Forest
CFS 5
77.31
76.26
74.65
Random Forest
CFS 10
78.3
74.68
74.04
FS – Feature selection, RIDER Stable– is the intersection of the features from manual
and ensemble segmentations with CCC > 0.95 on the RIDER data set, NLST Stable is
36 features stable across 3 time points for benign tumors on Cohort 2.
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CHAPTER 6: DATA SCIENCE BOWL 2017
6.1

Introduction
The Data Science Bowl 201778 presented by Kaggle and Booz Allen Hamilton was an

open competition to develop lung cancer detection algorithms. To this end awards of $1 million
were offered, with the top prize being $500,000. The competition was part of the Beau Biden
Cancer Moonshot.79 Congress passed the 21st Century Cures Act in 2016 allocating $1.8 Billion
in funding with $300 million to fund Moonshot initiatives in 2017. This competition’s goal was
the early detection of lung cancer and a reduction in false positives from improved algorithms.
This goal could help the 225,000 people in the United States lung cancer affects every year and
also reduce the associated $12 billion in healthcare costs.78
This competition presented some challenges not seen in our previous work on this topic.
We were not allowed to use data from the National Lung Screening Trial11 for supplemental
training data since it was not available to everyone. This NLST data set was our largest data set
for which we had segmentations for training. Another challenge was that no locations were given
for the nodules. Our current approach used a seed point within the nodule as a starting point for
semi-automated segmentation. Because of these challenges it was not clear if the competition
should be entered which caused a delay in the processing of the data. Still, in the end, we were
able to compete in a limited way in this competition.
6.2

Materials and Methods
The 506 cases of test data were downloaded from Kaggle’s servers and then entered into

HealthMyne80 software for segmentation by Alberto Garcia from the Moffitt Cancer Center. Two
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radiologists, Jin Qi and Wei Mu from Moffitt Cancer Center, segmented the lung nodules.
Mahmoud Abdalah, also from Moffitt Cancer Center, aligned the segmentations with the lung
images. Saeed Alahamri from the University of South Florida preprocessed the data, cropping
the images. Rahul Paul from the University of South Florida built a neural network classifier and
I built a random forests classifier.
6.2.1

Data
The competition opened on March 31st 2017 with the release of lung CTs for 1,397

training cases, 1,035 non-cancer and 362 with cancer, and a validation set of 198 cases. I used a
script provided by Oleg Trott to generate submissions to determine the validation results.81
Through repeated submissions the validation set labels were able to be determined. Because the
leader board gave results for each submission with 5 places of precision, each submission was
able to deduce 15 labels of the validation set. It was discovered that the validation set included
72 cases that were labeled as non-cancer and 28 cases with cancer. There was 74% of the
training set that was not labeled as developing cancer and 72% of the validation set with the
same label. The algorithms needed to provide a probability from the CT scans whether the
patient had lung cancer or would develop it in the next 12 months.
The evaluation metric used to judge an algorithm’s performance was logLoss, which
penalizes wrong guesses. A lower logLoss is better. The location of nodules was not given and a
patient could have no nodules or multiple nodules. On April 7th the test set was released. It
consisted of 506 unlabeled cases. On April 12th the contest concluded. The formula for logLoss78
is as follows:
1
!"#!"$$ = −
)

.

*+ ,"# *+ + 1 − *+ ,"# 1 − *+
+/0

where
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6.2.2

•

) is the number of patients in the test

•

*+ is the predicted probability of the image belonging to a patient with cancer

•

*+ is 1 if the diagnosis is cancer and 0 otherwise

•

,"# is the natural (base e) logarithm

Generating Predictions
Segmentation was performed using Healthmyne80 software. The software generated 203

image features. These features can be found in Supplemental Table B.5. These features were
input into Weka data mining software. A Random Forests classifier was built with 200 decision
trees trained on the validation set to output predictions on the test set. Another model was built
also using Random Forests but first selecting the 10 best features using relief-f. We did not have
the time to run our pipeline on the training data. It required an automatic segmentation of the
lung and then an automatic nodule finder/segmentor or a number of radiologists with no other
tasks.
6.3

Results
The model built using the Random Forests classifier received a logLoss score of 1.56555.

The model with Relief-f feature selection received a score of 1.57877. Lower scores are better.
Rahul Paul’s deep neural network obtained a score of 1.36361. We placed 369th out of 1972
teams with Rahul’s score. The winning score was 0.39975 by Liao Fangzhou and Zhe Li of
Tsinghua University.
6.4

Discussion
This competition was informative. It highlighted the need to be able to quickly input and

process large amounts of data. The reliance on human input for segmenting the nodules was a
bottleneck during the short time window for processing the test set. Also, the competition
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showed that the ability to change training sets is important. The NLST data set was the largest
training set that we had segmented so not using it required processing a new training set. Lastly it
showed the predictive power of deep convolutional neural networks,82 which the top two teams
used.
The winning team of Liao Fangzhou and Zhe Li had an approach that consisted of three
parts.83 The first part, preprocessing, started with segmenting the lung by applying a Gaussian
filter and then applying a threshold of -600 Hounsfield units. To remove interior artifacts the
convex hull algorithm and dilation were applied. The final stage of preprocessing normalized the
intensity of Hounsfield units to 0 to 255. Training data was obtained from this competition as
well as the LUNA1684 data set.
The second part of the algorithm was nodule detection. For this the winners used a 3D
convolutional neural network. For training, inputs were cube shapes cropped to 128x128x128.
These patches were selected to include 70% with nodules and 30% without nodules. Flipping the
image and resizing it augmented training data. Larger nodules were sampled with a higher
frequency to increase their number in the training set, as they were considered more predictive.
Hard negative sampling, where negative examples are built from false positives, was used to aid
performance.
Negative examples were randomly selected and ranked for classification and the top
examples used as hard negatives. The detector network was based on U-Net85 and was comprised
of 5 groups of 32x32x32 blocks and three different scales: 10mm, 30mm, and 60mm.
The last part of the algorithm was classification. After nodule detection, the top 5
candidate cubes of 32x32x32 were selected along with a dummy nodule in case segmentation
missed some nodules. Then max pooling was performed over the central 2x2x2 voxels and the
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result was passed to two fully connected layers. The final prediction accounts for the probability
of the dummy nodule as well as an additional loss parameter to facilitate training.
The second place team, which consisted of Daniel Hammack and Julian de Wit, came up
with two algorithms and then combined them with a weighted average. Daniel Hammack noted
that scans were around 30cmx30cm x40cm while a nodule, which can change the diagnosis, was
around 1cm3 or 1/36,000 of the whole scan. The author’s algorithms consisted of four steps.86
First he normalized for size to 1mm3 per voxel and intensity from a minimum of -1000
Hounsfield units mapping to 0 and a maximum of 400 Hounsfield units mapping to 1. The
second step consisted of detecting candidate nodule regions. Regions of 64mm3 were scored and
the top 50 chosen. The third step was to extract attributes: diameter, lobulation, spiculation, and
malignancy. Malignancy was the most important feature but the other features improved upon
malignancy when used alone. The author also notes that nodules found in the superior lobe were
more likely to be cancerous. A 3D convolutional neural network was built with leaky RELU and
max pooling layers. Training data was augmented with data from LUNA1684 as well as rotating
the contests training data.
The algorithm by Julian de Wit accounted for the second half of this team’s solution.87
His solution preprocesses the data in a similar way to his partner, normalizing voxels at 1mm3
and normalizing Hounsfield Units from 0 to1. The author stressed that in this competition
building the training set was perhaps the most important part. The training set was built from
5000 positive labels from LIDC34 weighted 5 times, 400,000 candidates from LUNA16,84 15,000
non-lung tissue edges of segmentation masks to learn the lung borders, and 7,000 LUNA16 false
positives weighted 3 times. The competition data segmented by the author was used for a second
model. The architecture for the neural network took a receptive field of 32mm.3 Next, average
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pooling of the z-axis to 2mm per voxel was performed. After that, 3D convolution layers with
RELU and max pooling layers were alternated four times. Finally a bottleneck layer was added
to train on intermediate features. As an addition the author added a strange nodule detector by
training a U-Net85 with examples from LUNA16.84 To detect large nodules the network predicted
at three scales: 1, 1.5, and 2 levels of zoom. Finally the resulting prediction was averaged with
Daniel Hammock’s algorithm.
The top two teams used 3D neural networks for nodule detection. This approach was well
suited to this competition. Competitions like this one help to point out weaknesses in our
workflow for classification. This competition was good practice for future competitions and
introduced novel ways of viewing lung cancer classification.
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CHAPTER 7: CONCLUSIONS
This dissertation presents an overview of radiomics and how it can be applied to lung
cancer. The challenges facing radiomics were presented as well as the current methods being
used to score CT scans. Both old and new articles on radiomics were examined as well as some
of the data sets used in these studies. Segmentation methods, classifiers, feature selectors,
performance metrics were also explained. Radiomics represents a promising avenue for research.
In my research I have focused on applying radiomic methods in lung cancer prediction
problems. With a decision tree classifier, adenocarcinoma patients with survival rates in the
lowest quartile were able to be differentiated from those in the longest surviving quartile with
77.5% accuracy.8 In another study, a radiomic model was able to predict whether a nodule was
benign or malignant using data from the National Lung Screening Trial at 80% accuracy.12
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CHAPTER 8: FUTURE WORK
8.1

Automated Nodule Detection
Segmenting is the first step of processing images for radiomic use and as such the

subsequent steps rely on an accurate segmentation. For this reason this work so far has relied on
the skill of radiologists to detect nodules and then segment the nodules. The radiologists are
aided by semi-automated methods of segmentation such as the “click and grow” algorithm but
they still must first find the nodule, click on it, and then make corrections to the resulting
segmentation. In practice this is a time consuming bottleneck to the radiomics workflow that
was highlighted in the Data Science Bowl. A solution to this bottleneck is fully automated
nodule detection and segmentation. This was the approach utilized by the winners of the Data
Science Bowl.
It is fairly easy to over detect nodules. Having a threshold of intensity will yield many
nodules from a scan. The problem is reducing the number of false positives. To solve over
detection a classifier can be employed to classify voxels and learn what is and is not a nodule.
Shih-Chung et al. utilized this approach of nodule detection with a back-propagation neural
network.88 They were able to obtain an AUC of 0.645 though their training set was rather small.
They trained on 60 nodules and tested on 174 nodules.
The winners of the Data Science Bowl, Liao Fangzhou and Zhe Li, coped with the
problem of over detection by choosing the top 5 candidate nodules to use in their classification.
The process of automated detection has room for growth and would go a long way to providing
fully automated classification.
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8.2

Neural Network Classification
Another avenue for improvement in the radiomics workflow is to find a more accurate

classifier. Neural networks have shown promise for their accuracy. Rahul Paul et al. improved
upon the accuracy of classifying short and long survival classes on a data set of 40 diagnostic
computed tomography images from Moffitt Cancer Center.89 Previously the best accuracy was
77.5% obtained using a decision tree classifier.8
The approach was to use neural network to extract deep features from a network trained
on other images. This is known as transfer learning when previous knowledge learned during
training is applied to a new unrelated topic. The transfer learning training set came from
ImageNet database.90 The trained MatConvNet convolutional neural network that performed the
best was vgg-f.
The design of the neural network consisted of five convolutional layers followed by 3
fully connected layers using a rectified linear unit (ReLU) as an activation function and dropout,
where random weights are not allowed to change. Features were obtained from the last hidden
layer. The architecture of the neural network is further describe in the work by Srivastava et al.91
and Dumoulin et al.92 The initial accuracy from extracted deep features matched the previous
accuracy of 77.5% however when deep features were combined with the previous image
features, an accuracy of 90% was obtained.
A random forests classifier was used with the 10 best features chosen using symmetric
uncertainty to rank the features. Five features were chosen from the deep features and five
features were chosen from the previously used quantitative image features. There is room for
improvement as the architecture and tuning of neural network improves. More accurate
classifiers, like neural networks, can improve the usefulness of radiomic decision support.
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8.3

Nodule Size Informed Classification
Another promising approach is to divide nodules into groups by size before classification.

This is the tact employed by Cherezov et al. to improve classification accuracy on the NLST data
set.93 The data set utilized was the National Lung Screening Trial cohorts used in the paper by
Hawkins et al.12 and described in the abstract by Schabath et al.10 In total there were 261 cases in
Cohort 1 and 237 cases in Cohort 2. The data set was divided into small nodules less than 8mm,
medium nodules 8mm or greater but less than 16mm, and large nodules 16mm or greater.
These three groups where classified with one of the following methods: decision trees,
rule based classification, Naïve Bayes, support vector machine with a radial basis function kernel
or linear kernel and cost and gamma chosen with a grid search, or random forests. Feature sets
consisted of 219 features extracted with Definiens describing size, shape, location, and texture,69
a subset of those including 23 features found to be stable on the RIDER data set in the paper by
Balagurunathan et al.,64 and 37 features found to be stable on Cohort 1.
In the first experiment used all sizes of Cohort 1 to test on the different groups of sizes
for Cohort 2. In this case large nodules in Cohort 2 were predicted the most accurately at 81.48%
compared to 73.22% for small and 74.69% for medium sized nodules and 74.68% overall. This
experiment was performed with a support vector machine and radial basis function kernel and
the RIDER stable features subset further selected to the 10 best features using Relief-f.
In the next experiment, the training data was separated by size and applied to the test data
of the corresponding size. In this way, overall accuracy, computed as the summation of
confusion matrices, rose to 81.01%. Three different classifiers were use: for small nodules Naïve
Bayes with the top 5 features found with relief-f from the RIDER stable features, for the medium
nodules a support vector machine with a radial basis function kernel with the top 10 features
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found with Relief-f from the RIDER stable features, and for large nodules Random Forests with
the top 5 features found with Relief-f from the Cohort 1 stable features.
Being able to select different classifiers for different sized nodules improved accuracy
nearly 7%, from 74.68% to 81.01%. With AUC as the criteria for comparison, the results were
less pronounced. AUC was improved from 0.78 with a random forests classifier when using all
of Cohort 1 for training to 0.81 with all three sizes using a Naïve Bayes classifier. This result was
improved slightly to 0.82 AUC when SMOTE94 was applied to generate more minority class
cases for training.
The number of features that were the same between classifiers for different sizes was
small with the notable exception of features for medium nodules compared to features for all
nodules that had an overlap of 8 of the 10 features. The standard deviation of accuracy and AUC
was higher for classifiers than it was for features showing that the classifiers play a more
prominent role than features when dividing by nodule size.
These improvements in accuracy and AUC from classifying nodules differently based on
their size shows a promising method for improvement. Different classifiers could be used for
only some of the sizes. Other types of classifiers such as neural networks could also be used.
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APPENDIX B: SUPPLEMENTAL TABLES
Table B.1: NLST patient IDs (PIDs) for each cohort.
SDLC 100012,100147,100913,100954,101068,102488,102658,104208,104386,104683,104
1 PIDs 815,105340,105974,107058,107434,107682,108352,109345,109573,109589,110253
,110987,111835,112258,112575,112901,115174,116279,116289,116837,117025,11
7820,118681,119358,119743,119924,120790,120954,121169,121999,122364,12351
5,124436,124864,125378,126792,126955,127400,127619,129553,130033,131174,1
31486,131979,133786,134257,200056,200397,201979,204694,204711,205687,2059
00,206359,207584,207647,207782,207857,208801,209029,209095,209512,209831,
212222,213413,213544,213630,213754,214728,215151,216160,216940,217245,217
877,218391
bPN 1 100186,100965,101012,101444,101467,101859,101996,102038,102082,102140,102
PIDs
315,102371,102516,102607,102620,102629,103303,103361,103458,103721,104250
,104302,104705,105042,105071,105085,105148,105205,105526,105808,105941,10
5949,106058,106990,107232,107237,107955,108392,108474,108504,108527,10857
7,108714,108834,108937,109237,109389,109538,109878,109897,109957,110522,1
10846,110878,111121,111200,111702,112183,112390,112957,113308,113665,1138
57,114263,114323,114958,115017,116329,116332,116420,117453,117947,118012,
118145,118226,118743,119173,119343,119958,120358,120378,120556,120762,121
130,121341,121438,121738,121967,122352,122392,122492,122541,122549,122652
,122766,122836,122965,123018,123344,123459,123559,123740,123909,125923,12
5982,126144,126254,126265,127000,127414,127886,128024,128275,128564,12882
9,129140,129741,130139,130231,130352,130544,130689,130692,130869,131122,1
31124,131465,131537,131800,132526,132529,132969,133700,134120,200525,2016
32,201701,202570,203168,203231,203372,203512,203578,203852,203981,204335,
204438,204604,204836,204859,205415,205617,205806,206344,206483,206809,208
107,208287,208794,209676,210231,210528,211423,211696,212827,212831,212849
,213038,213769,214097,214377,214487,214632,216308,218248,218666
SDLC
2 PIDs

100658,100681,101192,101428,101692,103359,103621,104999,105165,106194,106
553,107211,107910,108061,109965,111454,112506,113820,115020,115571,117950
,118297,118553,118602,118719,119129,120070,120393,120573,121852,122117,12
2376,122590,123810,123891,124323,125727,126823,128899,129511,129534,13161
1,131963,132313,132823,133076,134491,134503,200129,200221,200628,200925,2
02611,202748,202814,202822,203536,203759,204513,206737,206870,207830,2091
19,209445,210090,210419,210612,210653,210754,211965,212202,212522,212718,
213439,213442,213734,214553,214672,214700,215316,215325,216422,216973,217
203,218510
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Table B.1 (Continued)
bPN 2 100005,100095,100414,100629,100727,101321,101563,101694,102154,102641,102
PIDs
691,103239,103874,104355,104377,104769,104792,104871,105617,105632,106226,
106957,107579,107725,108320,108461,108539,108600,108921,109031,109127,110
286,110775,110802,110919,110994,111452,112180,112220,112606,112786,112961,
113014,113871,114517,114656,114796,115123,115175,115772,115794,116383,117
406,117490,117610,118243,118745,119485,119533,119568,119894,119934,120593,
120885,121588,121657,121854,122078,122159,122378,122577,123062,123281,123
884,124607,124913,125028,125413,125697,125898,126101,126581,126622,126718,
126814,126928,127048,127731,127996,128033,128535,128601,128714,128852,129
703,129734,130117,130173,130896,130950,131986,132535,132885,133207,133308,
133789,133991,134309,200268,200834,201368,201446,201737,201890,202709,202
873,203344,203921,203930,204238,204377,204494,205023,205964,206925,208147,
209137,209318,209852,210198,210362,210483,210700,211092,212200,213139,213
215,214270,215213,215446,215626,215687,216089,216411,216666,216790,217021,
217676,218217,218320,218383,218662
Table B.2: 3D Image features computed with Definiens software.
Longest
Diameter
[mm]
Short Axis *
Longest
Diameter
[mm²]
Short Axis
[mm]
Mean [HU]

Area (Pxl)

3D Laws features
E5 L5 L5 Layer 1

3D Laws features R5 L5
W5 Layer 1

3D Wavelet decomposition. P2
L2 C10 Layer 1

Volume (Pxl)

3D Laws features
E5 L5 R5 Layer 1

3D Laws features R5 R5 E5
Layer 1

3D Wavelet decomposition. P2
L2 C11 Layer 1

Number of pixels

StdDev [HU]

Thickness (Pxl)

Volume [cm³]

Length (Pxl)

5a_3D_MacS
pic_NumberO
f
8a_3D_Is_Att
ached_To_Ple
ural_Wall
8b_3D_Relati
ve_Border_T
o_Lung
8c_3D_Relati
ve_Border_T
o_PleuralWall
8d_3D_Ratio
_Free_To_Att
ached
9a_3D_Fracti
onalAnisotrop
y

Length/Thickness

3D Laws features
E5 L5 S5 Layer 1
3D Laws features
E5 L5 W5 Layer 1
3D Laws features
E5 R5 E5 Layer 1
3D Laws features
E5 R5 L5 Layer 1
3D Laws features
E5 R5 R5 Layer 1

3D Laws features
Layer 1
3D Laws features
Layer 1
3D Laws features
Layer 1
3D Laws features
W5 Layer 1
3D Laws features
Layer 1

3D Wavelet decomposition.
L2 C12 Layer 1
3D Wavelet decomposition.
L2 C13 Layer 1
3D Wavelet decomposition.
L2 C14 Layer 1
3D Wavelet decomposition.
L2 C15 Layer 1
3D Wavelet decomposition.
L2 C1 Layer 1

Length/Width

3D Laws features
E5 R5 S5 Layer 1

3D Laws features R5 S5 L5
Layer 1

3D Wavelet decomposition. P2
L2 C2 Layer 1

Border length (Pxl)

3D Laws features
E5 R5 W5 Layer 1

3D Laws features R5 S5 R5
Layer 1

3D Wavelet decomposition. P2
L2 C3 Layer 1

avgCoocurrence-Homo

3D Laws features
E5 S5 E5 Layer 1

3D Laws features R5 S5 S5
Layer 1

3D Wavelet decomposition. P2
L2 C4 Layer 1

avgCoocurrence-MP

3D Laws features
E5 S5 L5 Layer 1

3D Laws features R5 S5
W5 Layer 1

3D Wavelet decomposition. P2
L2 C5 Layer 1

3D Laws features
L5 R5 S5 Layer 1

9b_3D_Circul
arity

avgCoocurrenceenergy

9c_3D_Comp
actness

avgCoocurrenceentropy

3D Laws
features R5
W5 E5 Layer
1
3D Laws
features R5
W5 L5 Layer
1
3D Laws
features R5
W5 R5
Layer 1

3D Laws
features
W5 R5 R5
Layer 1
3D Laws
features
W5 R5 S5
Layer 1
3D Laws
features
W5 S5 E5
Layer 1

Width (Pxl)

avgCoocurrencecontrast

3D Laws
features E5
S5 R5 Layer
1
3D Laws
features E5
S5 S5 Layer
1
3D Laws
features E5
S5 W5 Layer
1

3D Laws features
L5 R5 W5 Layer 1
3D Laws features
L5 S5 E5 Layer 1
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R5 R5 L5
R5 R5 R5
R5 R5 S5
R5 R5
R5 S5 E5

3D Laws
features S5
S5 L5
Layer 1
3D Laws
features S5
S5 R5
Layer 1
3D Laws
features S5
S5 S5
Layer 1

P2
P2
P2
P2
P2

3D Wavelet
decomposition.
P2 L2 C6 Layer
1
3D Wavelet
decomposition.
P2 L2 C7 Layer
1
3D Wavelet
decomposition.
P2 L2 C8 Layer
1

Table B.2 (Continued)
9d_3D_AV_
Dist_COG_T
o_Border_[m
m]
9e_3D_SD_D
ist_COG_To_
Border_[mm]

avgCoocurrencemean

9f_3D_MIN_
Dist_COG_T
o_Border_[m
m]
9g_3D_MAX
_Dist_COG_
To_Border_[
mm]
10a_3D_Relat
ive_Volume_
AirSpaces

avgHGRE

10b_3D_Num
ber_AirSpace
s

avgLRHGE

10c_3D_Av_
Volume_AirS
paces_[mm³]

avgLRLGE

10d_3D_SD_
Volume_AirS
paces_[mm³]

avgRLN

Asymmetry

avgRP

Compactness

avgSRE

Density

avgSRHGE

Elliptic Fit

avgSRLGE

Main
direction

3D Laws features
E5 E5 E5 Layer
1

Radius of
largest
enclosed
ellipse
Radius of
smallest
enclosing
ellipse
Shape index

3D Laws features
E5 E5 L5 Layer
1

avgGLN

avgLGRE

avgLRE

3D Laws features
E5 E5 R5 Layer
1
3D Laws features
E5 E5 S5 Layer
1

3D Laws
features E5
W5 E5 Layer
1
3D Laws
features E5
W5 L5 Layer
1
3D Laws
features E5
W5 R5
Layer 1
3D Laws
features E5
W5 S5 Layer
1
3D Laws
features E5
W5 W5
Layer 1
3D Laws
features L5
E5 E5 Layer
1
3D Laws
features L5
E5 L5 Layer
1
3D Laws
features L5
E5 R5 Layer
1
3D Laws
features L5
E5 S5 Layer
1
3D Laws
features L5
E5 W5 Layer
1
3D Laws
features L5
L5 E5 Layer
1
3D Laws
features L5
L5 L5 Layer
1
3D Laws
features L5
L5 R5 Layer
1
3D Laws
features L5
L5 S5 Layer
1
3D Laws
features L5
L5 W5 Layer
1
3D Laws
features L5
R5 E5 Layer
1

3D Laws features
L5 S5 L5 Layer 1
3D Laws features
L5 S5 R5 Layer 1
3D Laws features
L5 S5 S5 Layer 1
3D Laws features
L5 S5 W5 Layer 1
3D Laws features
L5 W5 E5 Layer 1
3D Laws features
L5 W5 L5 Layer 1
3D Laws features
L5 W5 R5 Layer 1
3D Laws features
L5 W5 S5 Layer 1
3D Laws features
L5 W5 W5 Layer
1
3D Laws features
R5 E5 E5 Layer 1
3D Laws features
R5 E5 L5 Layer 1
3D Laws features
R5 E5 R5 Layer 1
3D Laws features
R5 E5 S5 Layer 1
3D Laws features
R5 E5 W5 Layer 1
3D Laws features
R5 L5 E5 Layer 1
3D Laws features
R5 L5 L5 Layer 1
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3D Laws
features R5
W5 S5 Layer
1
3D Laws
features R5
W5 W5
Layer 1
3D Laws
features S5
E5 E5 Layer
1
3D Laws
features S5
E5 L5 Layer
1
3D Laws
features S5
E5 R5 Layer
1
3D Laws
features S5
E5 S5 Layer
1
3D Laws
features S5
E5 W5 Layer
1
3D Laws
features S5
L5 E5 Layer
1
3D Laws
features S5
L5 L5 Layer
1
3D Laws
features S5
L5 R5 Layer
1
3D Laws
features S5
L5 S5 Layer
1
3D Laws
features S5
L5 W5 Layer
1
3D Laws
features S5
R5 E5 Layer
1
3D Laws
features S5
R5 L5 Layer
1
3D Laws
features S5
R5 R5 Layer
1
3D Laws
features S5
R5 S5 Layer
1

3D Laws
features S5
S5 W5
Layer 1
3D Laws
features S5
W5 E5
Layer 1
3D Laws
features S5
W5 L5
Layer 1
3D Laws
features S5
W5 R5
Layer 1
3D Laws
features S5
W5 S5
Layer 1
3D Laws
features S5
W5 W5
Layer 1
3D Laws
features
W5 E5 E5
Layer 1
3D Laws
features
W5 E5 L5
Layer 1
3D Laws
features
W5 E5 R5
Layer 1
3D Laws
features
W5 E5 S5
Layer 1
3D Laws
features
W5 E5 W5
Layer 1
3D Laws
features
W5 L5 E5
Layer 1
3D Laws
features
W5 L5 L5
Layer 1
3D Laws
features
W5 L5 R5
Layer 1
3D Laws
features
W5 L5 S5
Layer 1
3D Laws
features
W5 L5 W5
Layer 1

3D Laws
features
W5 S5 L5
Layer 1
3D Laws
features
W5 R5 W5
Layer 1
3D Laws
features
W5 S5 R5
Layer 1
3D Laws
features
W5 S5 S5
Layer 1
3D Laws
features
W5 S5 W5
Layer 1
3D Laws
features
W5 W5 E5
Layer 1
3D Laws
features
W5 W5 L5
Layer 1
3D Laws
features
W5 W5 R5
Layer 1
3D Laws
features
W5 W5 S5
Layer 1
3D Laws
features
W5 W5 W5
Layer 1
Histogram
Mean
Layer 1

3D Wavelet
decomposition.
P1 L2 C11
Layer 1
3D Wavelet
decomposition.
P1 L2 C10
Layer 1
3D Wavelet
decomposition.
P1 L2 C12
Layer 1
3D Wavelet
decomposition.
P1 L2 C13
Layer 1
3D Wavelet
decomposition.
P1 L2 C14
Layer 1
3D Wavelet
decomposition.
P1 L2 C15
Layer 1
3D Wavelet
decomposition.
P1 L2 C1 Layer
1
3D Wavelet
decomposition.
P1 L2 C2 Layer
1
3D Wavelet
decomposition.
P1 L2 C3 Layer
1
3D Wavelet
decomposition.
P1 L2 C4 Layer
1
3D Wavelet
decomposition.
P1 L2 C5 Layer
1
Histogram
3D Wavelet
SD Layer 1
decomposition.
P1 L2 C6 Layer
1
Histogram
3D Wavelet
ENERGY
decomposition.
Layer 1
P1 L2 C7 Layer
1
Histogram
3D Wavelet
ENTROPY
decomposition.
Layer 1
P1 L2 C8 Layer
1
Histogram KUR Layer 1

Histogram SKEW Layer 1

Table B.2 (Continued)
Roundness

3D Laws features
E5 E5 W5 Layer
1

Rectangular
Fit

3D Laws features
E5 L5 E5 Layer
1

3D Laws
features L5
R5 L5 Layer
1
3D Laws
features L5
R5 R5 Layer
1

3D Laws features
R5 L5 R5 Layer 1
3D Laws features
R5 L5 S5 Layer 1

3D Laws
features S5
R5 W5
Layer 1
3D Laws
features S5
S5 E5 Layer
1

3D Laws
features
W5 R5 E5
Layer 1
3D Laws
features
W5 R5 L5
Layer 1

3D Wavelet decomposition. P2
L2 C9 Layer 1
3D Wavelet decomposition. P1
L2 C9 Layer 1

Table B.3: Image features that were stable on the RIDER data set.
Feature
Category
Longest Diameter [mm]
Size
Short Axis * Longest Diameter [mm_]
Size
Short Axis [mm]
Size
Mean [HU]
Pixel Histogram
StdDev [HU]
Pixel Histogram
Volume [cm_]
Size
5a_3D_MacSpic_NumberOf
Shape
8a_3D_Is_Attached_To_Pleural_Wall
Location
8b_3D_Relative_Border_To_Lung
Location
8c_3D_Relative_Border_To_PleuralWall
Location
9b_3D_Circularity
Shape
9e_3D_SD_Dist_COG_To_Border_[mm]
Location
9g_3D_MAX_Dist_COG_To_Border_[mm] Location
Asymmetry
Shape
Roundness
Shape
Volume (Pxl)
Size
Number of pixels
Shape
Length/Width
Size
avgRLN
Co-occurrence and
Run Length
3D Laws features E5 E5 L5 Layer 1
Laws
3D Laws features E5 E5 R5 Layer 1
Laws
3D Laws features E5 W5 L5 Layer 1
Laws
3D Laws features L5 W5 L5 Layer 1
Laws
Table B.4: Image features that were stable on the NLST Cohort 1 time 0 data set
Longest Diameter [mm]
Size
Short Axis * Longest Diameter
Size
[mm_]
Short Axis [mm]
Size
Mean [HU]
Pixel Histogram
Volume [cm_]
Size
8a_3D_Is_Attached_To_Pleural_Wa Location
ll
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Table B.4 (Continued)
8b_3D_Relative_Border_To_Lung
8c_3D_Relative_Border_To_Pleural
Wall
9c_3D_Compactness
9d_3D_AV_Dist_COG_To_Border
_[mm]
9e_3D_SD_Dist_COG_To_Border_
[mm]
9f_3D_MIN_Dist_COG_To_Border
_[mm]
9g_3D_MAX_Dist_COG_To_Bord
er_[mm]
10a_3D_Relative_Volume_AirSpac
es
10b_3D_Number_AirSpaces
10c_3D_Av_Volume_AirSpaces_[
mm_]
Compactness
Shape index
Area (Pxl)
Volume (Pxl)
Number of pixels
Width (Pxl)
Thickness (Pxl)
Length (Pxl)
Border length (Pxl)
avgGLN
avgHGRE
avgLRHGE
avgRLN
avgRP
avgSRHGE
3D Laws features L5 L5 L5 Layer 1
Histogram ENTROPY Layer 1
Histogram SKEW Layer 1
3D Wavelet decomposition. P2 L2
C13 Layer 1
3D Wavelet decomposition. P2 L2
C14 Layer 1
3D Wavelet decomposition. P2 L2
C15 Layer 1

Location
Location
Location
Location
Location
Location
Location
Location
Location
Location
Shape
Shape
Size
Size
Size
Size
Size
Size
Size
Co-occurrence and Run Length
Co-occurrence and Run Length
Co-occurrence and Run Length
Co-occurrence and Run Length
Co-occurrence and Run Length
Co-occurrence and Run Length
Laws
Pixel Histogram
Pixel Histogram
Wavelets
Wavelets
Wavelets
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Table B.5: 203 Health Myne image features.
AVG_DENSITY

GLCM_CONTR
AST_HU_POSX
POSZ

GLCM_HOMOGE
NEITY_HU_POS
X

GLCM_VARIAN
CE_HU_NEGXPO
SZ

L2_DISTANCE_
MM

LARGEST_DIAM
ETER_START_V
OXELS_Y

CENTROID_X_
MM

GLCM_CONTR
AST_HU_POSY

GLCM_HOMOGE
NEITY_HU_POS
XPOSY

GLCM_VARIAN
CE_HU_NEGYPO
SZ

L2_UNIT_AXIS_
X_MM

LARGEST_DIAM
ETER_START_V
OXELS_Z

CENTROID_Y_
MM

GLCM_CONTR
AST_HU_POSY
POSZ

GLCM_HOMOGE
NEITY_HU_POS
XPOSZ

GLCM_VARIAN
CE_HU_POSX

L2_UNIT_AXIS_
Y_MM

LARGEST_DIAM
ETER_VOXELS

CENTROID_Z_
MM

GLCM_CONTR
AST_HU_POSZ

GLCM_HOMOGE
NEITY_HU_POS
Y

GLCM_VARIAN
CE_HU_POSXPO
SY

L2_UNIT_AXIS_
Z_MM

LARGEST_PLAN
AR_DIAMETER_
END_MM_X

COMPACTNESS
1_MM

GLCM_ENERG
Y_HU_NEGXPO
SY

GLCM_HOMOGE
NEITY_HU_POS
YPOSZ

GLCM_VARIAN
CE_HU_POSXPO
SZ

L3_AXIS_END_X
_MM

LARGEST_PLAN
AR_DIAMETER_
END_MM_Y

COMPACTNESS
2_MM

GLCM_ENERG
Y_HU_NEGXPO
SZ

GLCM_HOMOGE
NEITY_HU_POS
Z

GLCM_VARIAN
CE_HU_POSY

L3_AXIS_END_Y
_MM

LARGEST_PLAN
AR_DIAMETER_
END_MM_Z

ENERGY_HU

GLCM_ENERG
Y_HU_NEGYPO
SZ
GLCM_ENERG
Y_HU_POSX

GLCM_MEAN_H
U_NEGXPOSY

GLCM_VARIAN
CE_HU_POSYPO
SZ
GLCM_VARIAN
CE_HU_POSZ

L3_AXIS_END_Z
_MM

GLCM_ENERG
Y_HU_POSXPO
SY
GLCM_ENERG
Y_HU_POSXPO
SZ
GLCM_ENERG
Y_HU_POSY

GLCM_MEAN_H
U_NEGYPOSZ

KURTOSIS_HU

L3_AXIS_START
_Y_MM

GLCM_MEAN_H
U_POSX

L1_AXIS_END_X
_MM

L3_AXIS_START
_Z_MM

GLCM_MEAN_H
U_POSXPOSY

L1_AXIS_END_Y
_MM

L3_DISTANCE_
MM

GLCM_ENERG
Y_HU_POSYPO
SZ
GLCM_ENERG
Y_HU_POSZ

GLCM_MEAN_H
U_POSXPOSZ

L1_AXIS_END_Z
_MM

L3_UNIT_AXIS_
X_MM

GLCM_MEAN_H
U_POSY

L1_AXIS_START
_X_MM

L3_UNIT_AXIS_
Y_MM

LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_X
LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_Y
LARGEST_PLAN
AR_DIAMETER_
END_VOXELS_Z
LARGEST_PLAN
AR_DIAMETER_
MM
LARGEST_PLAN
AR_DIAMETER_
START_MM_X
LARGEST_PLAN
AR_DIAMETER_
START_MM_Y
LARGEST_PLAN
AR_DIAMETER_
START_MM_Z

ENTROPY_HU
FOOTPRINT_X_
MM
FOOTPRINT_Y_
MM
FOOTPRINT_Z_
MM
GLCM_AUTOC
ORRELATION_
HU_NEGXPOSY
GLCM_AUTOC
ORRELATION_
HU_NEGXPOSZ

GLCM_MEAN_H
U_NEGXPOSZ

L3_AXIS_START
_X_MM
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LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
MM_Y
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
MM_Z
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_X
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_Y
LARGEST_PLAN
AR_ORTHO_DIA
METER_START_
VOXELS_Z
LARGEST_PLAN
AR_ORTHO_DIA
METER_VOXEL
S
LUNG_RADS

PERCENT_SOLI
D_INCL_AIR

VOLUME_ML

RECIST_PATIEN
T_NADIR

VOLUME_MM3

RECIST_PERCEN
T_CHANGE_FRO
M_BL

VOLUME_VOX
ELS

LUNG_RADS_DI
AMETER_MM

RECIST_TIME_P
OINT

LUNG_RADS_IS
OLATION

ROOT_MEAN_S
QUARE

LUNG_RADS_RE
ASONING_CODE

SEED_POINT_US
ER_GRID_X

MASS_GRAMS

SEED_POINT_US
ER_GRID_Y

MAX_HU

SEED_POINT_US
ER_GRID_Z

MAX_VOXELS

SEED_POINT_US
ER_PATIENT_X

RECIST_PERCEN
T_CHANGE_FRO
M_NADIR
RECIST_SCORE_
PATIENT
RECIST_SUM

RECIST_TARGE
T_LESION

Table B.5 (Continued)
GLCM_AUTOC
ORRELATION_
HU_NEGYPOS
Z
GLCM_AUTOC
ORRELATION_
HU_POSX

GLCM_ENTROP
Y_HU_NEGXPOS
Y

GLCM_MEAN_H
U_POSYPOSZ

L1_AXIS_START
_Y_MM

L3_UNIT_AXIS_
Z_MM

LARGEST_PLAN
MEAN_DEVIATI
SEED_POINT_US
AR_DIAMETER_
ON_HU
ER_PATIENT_Y
START_VOXELS
_X
GLCM_ENTROP
GLCM_MEAN_H
L1_AXIS_START
LARGEST_DIAM
LARGEST_PLAN
MEAN_HU
SEED_POINT_US
Y_HU_NEGXPOS U_POSZ
_Z_MM
ETER_END_MM
AR_DIAMETER_
ER_PATIENT_Z
Z
_X
START_VOXELS
_Y
GLCM_AUTOC
GLCM_ENTROP
GLCM_STD_HU_ L1_DISTANCE_
LARGEST_DIAM
LARGEST_PLAN
MEAN_VOXELS
SKEWNESS_HU
ORRELATION_
Y_HU_NEGYPOS NEGXPOSY
MM
ETER_END_MM
AR_DIAMETER_
HU_POSXPOSY Z
_Y
START_VOXELS
_Z
GLCM_AUTOC
GLCM_ENTROP
GLCM_STD_HU_ L1_UNIT_AXIS_
LARGEST_DIAM
LARGEST_PLAN
MEDIAN_HU
SPHERICAL_DIS
ORRELATION_
Y_HU_POSX
NEGXPOSZ
X_MM
ETER_END_MM
AR_DIAMETER_
PROPORTION_M
HU_POSXPOSZ
_Z
VOXELS
M
GLCM_AUTOC
GLCM_ENTROP
GLCM_STD_HU_ L1_UNIT_AXIS_
LARGEST_DIAM
LARGEST_PLAN
MEDIAN_VOXE
SPHERICITY_M
ORRELATION_
Y_HU_POSXPOS
NEGYPOSZ
Y_MM
ETER_END_VOX AR_ORTHO_DIA
LS
M
HU_POSY
Y
ELS_X
METER_END_M
M_X
GLCM_AUTOC
GLCM_ENTROP
GLCM_STD_HU_ L1_UNIT_AXIS_
LARGEST_DIAM
LARGEST_PLAN
MIN_HU
STD_DEV_HU
ORRELATION_
Y_HU_POSXPOS
POSX
Z_MM
ETER_END_VOX AR_ORTHO_DIA
HU_POSYPOSZ
Z
ELS_Y
METER_END_M
M_Y
GLCM_AUTOC
GLCM_ENTROP
GLCM_STD_HU_ L2_AXIS_END_X LARGEST_DIAM
LARGEST_PLAN
MIN_VOXELS
SURFACE_AREA
ORRELATION_
Y_HU_POSY
POSXPOSY
_MM
ETER_END_VOX AR_ORTHO_DIA
_MM2
HU_POSZ
ELS_Z
METER_END_M
M_Z
GLCM_CONTRAS
GLCM_ENTROPY_
GLCM_STD_HU_P
L2_AXIS_END_Y_
LARGEST_DIAMET LARGEST_PLANA
NODULE_TYPE
SURFACE_AREA_
T_HU_NEGXPOS
HU_POSYPOSZ
OSXPOSZ
MM
ER_MM
R_ORTHO_DIAME
TO_VOLUME_RA
Y
TER_END_VOXELS
TIO_MM
_X
GLCM_CONTR
GLCM_ENTROP
GLCM_STD_HU_ L2_AXIS_END_Z
LARGEST_DIAM
LARGEST_PLAN
NORMALIZED_
TIME_POINT_RE
AST_HU_NEGX Y_HU_POSZ
POSY
_MM
ETER_START_M
AR_ORTHO_DIA
ABOVE_MEAN_
LATIVE
POSZ
M_X
METER_END_V
DEVIATION_HU
OXELS_Y
GLCM_CONTR
GLCM_HOMOGE GLCM_STD_HU_ L2_AXIS_START
LARGEST_DIAM
LARGEST_PLAN
PART_SOLID_DI
UNIFORMITY_A
AST_HU_NEGY NEITY_HU_NEG
POSYPOSZ
_X_MM
ETER_START_M
AR_ORTHO_DIA
AMETER_MM
CR
POSZ
XPOSY
M_Y
METER_END_V
OXELS_Z
GLCM_CONTR
GLCM_HOMOGE GLCM_STD_HU_ L2_AXIS_START
LARGEST_DIAM
LARGEST_PLAN
PERCENT_GGO
UNIFORMITY_H
AST_HU_POSX
NEITY_HU_NEG
POSZ
_Y_MM
ETER_START_M
AR_ORTHO_DIA
U
XPOSZ
M_Z
METER_MM
GLCM_CONTR
GLCM_HOMOGE GLCM_VARIAN
L2_AXIS_START
LARGEST_DIAM
LARGEST_PLAN
PERCENT_SOLI
VARIANCE_HU
AST_HU_POSX
NEITY_HU_NEG
CE_HU_NEGXPO _Z_MM
ETER_START_V
AR_ORTHO_DIA
D
POSY
YPOSZ
SY
OXELS_X
METER_START_
MM_X
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